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1. INTRODUCTION {#mgg3950-sec-0005}
===============

Genome‐wide association studies (GWAS) predominantly from Caucasian and Asian populations have identified several single nucleotide polymorphisms (SNPs) associated with blood pressure (BP; Cho et al., [2009](#mgg3950-bib-0005){ref-type="ref"}; Evangelou et al., [2018](#mgg3950-bib-0011){ref-type="ref"}; Levy et al., [2009](#mgg3950-bib-0027){ref-type="ref"}; Qian, Lu, Tan, Liu, & Lu, [2007](#mgg3950-bib-0044){ref-type="ref"}; Warren et al., [2017](#mgg3950-bib-0053){ref-type="ref"}; Xi et al., [2014](#mgg3950-bib-0055){ref-type="ref"}). Despite having a high burden of hypertension, and opportunities for improved fine‐mapping of causative variants, including higher genetic diversity and lower linkage disequilibrium (LD; Addo, Smeeth, & Leon, [2007](#mgg3950-bib-0001){ref-type="ref"}; Luoni et al., [2005](#mgg3950-bib-0033){ref-type="ref"}; Noubiap et al., [2017](#mgg3950-bib-0039){ref-type="ref"}; Tishkoff et al., [2009](#mgg3950-bib-0049){ref-type="ref"}), African populations are underrepresented in published genetic studies of BP (Peprah, Xu, Tekola‐Ayele, & Royal, [2015](#mgg3950-bib-0042){ref-type="ref"}). Among 38 studies that investigated genetic polymorphisms associated with hypertension in Africa‐based populations (participant numbers ranging from 65 to 1939) reviewed in (Yako et al., [2018](#mgg3950-bib-0056){ref-type="ref"}), all adopted a candidate gene approach rather than conducting a GWAS. It remains unclear whether variants associated with BP in non‐African populations also influence BP among Africans or whether the patterns of genetic susceptibility differ markedly.

Blood pressure GWASs conducted among populations of African origin in the diaspora are rare, and often report different variants associated with BP compared to those reported in non‐African populations (Adeyemo et al., [2009](#mgg3950-bib-0002){ref-type="ref"}; Fox et al., [2011](#mgg3950-bib-0012){ref-type="ref"}; Franceschini et al., [2013](#mgg3950-bib-0013){ref-type="ref"}; Kidambi et al., [2012](#mgg3950-bib-0026){ref-type="ref"}; Liang et al., [2017](#mgg3950-bib-0029){ref-type="ref"}). Attempts to replicate genetic findings in independent populations have returned mixed results (Kayima et al., [2017](#mgg3950-bib-0025){ref-type="ref"}; Kidambi et al., [2012](#mgg3950-bib-0026){ref-type="ref"}; Li et al., [2017](#mgg3950-bib-0028){ref-type="ref"}; Xi et al., [2014](#mgg3950-bib-0055){ref-type="ref"}). The largest African American GWAS of BP included a meta‐analysis of 29,378 individuals, and identified only one (the *SOX6* locus) of the five loci that were associated with BP in a multiethnic (African American, European and East Asian) sample of 99,382 individuals (Franceschini et al., [2013](#mgg3950-bib-0013){ref-type="ref"}). Of the 17 SNPs most strongly associated with BP (*p* \< 1 × 10^−4^) in African Americans, three SNPS were replicated (*p* \< .05) in a West African sample (Adeyemo et al., [2009](#mgg3950-bib-0002){ref-type="ref"}). Among Ugandan adults, 11 out of 27 BP related candidate SNPs (selected because of previous association with BP from BP GWASs or admixture mapping analysis) were replicated (*p* \< .05) with eight of the 11 SNPs having the same effect direction as in the discovery sample (Kayima et al., [2017](#mgg3950-bib-0025){ref-type="ref"}).

Twin studies report that over 30% of BP variability is heritable (Biron, Mongeau, & Bertrand, [1976](#mgg3950-bib-0004){ref-type="ref"}; Williams et al., [1991](#mgg3950-bib-0054){ref-type="ref"}) but established variants associated with BP account for only 2%--5% of BP variation (Ehret & Caulfield, [2013](#mgg3950-bib-0007){ref-type="ref"}; Salfati, Morrison, Boerwinkle, & Chakravarti, [2015](#mgg3950-bib-0045){ref-type="ref"}). This strongly suggests the existence of important undiscovered variants. This "missing heritability" could be due to rare or to common SNPs, all conferring small increases or decreases in expected BP (Maher, [2008](#mgg3950-bib-0034){ref-type="ref"}; Manolio et al., [2009](#mgg3950-bib-0035){ref-type="ref"}). There is a need for both GWAS and replication studies to further elucidate and improve the generalizability of BP genetic findings.

The role of environmental and of lifestyle factors in hypertension among Africans is well documented as reviewed previously (Addo et al., [2007](#mgg3950-bib-0001){ref-type="ref"}; Noubiap et al., [2017](#mgg3950-bib-0039){ref-type="ref"}). Previously, we described the role of environmental and of lifestyle factors in adolescents' BP and the findings were reported in (Lule, Namara, Akurut, Lubyayi, et al., [2019](#mgg3950-bib-0031){ref-type="ref"}; Lule, Namara, Akurut, Muhangi, et al., [2019](#mgg3950-bib-0032){ref-type="ref"}). However, the contribution of genetic variants remains unknown and understudied (Yako et al., [2018](#mgg3950-bib-0056){ref-type="ref"}). It is not clear whether genetic loci associated with hypertension among populations of non‐African origin influence susceptibility to or protection from hypertension in populations on the African continent. Independent confirmation is necessary to validate BP SNPs in different populations. We used data from the Entebbe Mother and Baby Study (EMaBS) birth cohort (Elliott et al., [2007](#mgg3950-bib-0010){ref-type="ref"}) to conduct 1) a GWAS of systolic and diastolic BP and 2) a replication study of candidate SNPs identified in previously published BP GWASs. The GWAS aimed to identify novel BP loci unique to this population while candidate gene analysis aimed to identify variants influencing BP across different ethnic groups.

We hypothesized that genetic variants (either unique or not unique to populations in Africa) would be associated with BP among Ugandan adolescents. Individuals of African origin have different genetic makeup from individuals of non‐African ancestries (Addo et al., [2007](#mgg3950-bib-0001){ref-type="ref"}; Luoni et al., [2005](#mgg3950-bib-0033){ref-type="ref"}; Noubiap et al., [2017](#mgg3950-bib-0039){ref-type="ref"}; Tishkoff et al., [2009](#mgg3950-bib-0049){ref-type="ref"}). Identifying genetic variants associated with BP enhances our understanding of BP regulation and might highlight potential drug targets for hypertension treatment and prevention. Furthermore, the identification of variants associated with hypertension in both adolescence and adulthood could offer opportunities for early risk prediction.

2. METHODS {#mgg3950-sec-0006}
==========

2.1. Ethical compliance {#mgg3950-sec-0007}
-----------------------

This study was approved by the Uganda Virus Research Institute Science and Ethics Committee; the Uganda National Council for Science & Technology; the London School of Hygiene & Tropical Medicine; and the Oxford Tropical Research Ethics Committee. Written informed assent and consent were obtained.

2.2. Study design, population and setting {#mgg3950-sec-0008}
-----------------------------------------

The EMaBS \[trial registration ISRCTN32849447\] in Uganda, was originally designed to investigate the influence of worms and their treatment in pregnancy and early childhood on vaccine response and on infections in childhood (Elliott et al., [2007](#mgg3950-bib-0010){ref-type="ref"}). Briefly, between April 2003 and November 2005, 2,507 pregnant women in their second or third trimester were randomized in a 2 × 2 factorial design to receive single dose albendazole (400 mg) or matching placebo and single dose praziquantel (40 mg/kg) or matching placebo. At 15 months of age, the resulting 2,345 live‐born infants were randomized to receive quarterly albendazole or matching placebo up to 5 years of age.

2.3. Phenotyping {#mgg3950-sec-0009}
----------------

The offspring continued under follow‐up after the trial ended in 2011. From 20 May 2014 to 16 June 2016, cohort participants who were now aged 10--11 years were enrolled in a BP sub‐study, as part of which additional anthropometric and BP data were collected (Lule, Namara, Akurut, Muhangi, et al., [2019](#mgg3950-bib-0032){ref-type="ref"}). Adolescents were included in this study if they were aged 10 or 11 years and attending their routine annual follow‐up visit during the BP sub‐study period (11‐year‐olds who had previously enrolled as 10‐year‐olds were not included twice). Where necessary, enrollment was postponed until the participant was free of malaria (fever or axillary temperature ≥37.5°C and parasitemia) and other illnesses (Lule, Namara, Akurut, Muhangi, et al., [2019](#mgg3950-bib-0032){ref-type="ref"}).

BP was measured as previously described (Lule, Namara, Akurut, Muhangi, et al., [2019](#mgg3950-bib-0032){ref-type="ref"}). Briefly, on the BP study visit day, after 5 min rest period, trained nurses measured BP thrice 5 min apart, on the right arm supported at the heart level, with the participant seated upright all the way to the back of the chair, with legs uncrossed and feet flat on the floor. Automated Omron (M6, HEM‐700) machines validated every 6 months by the Uganda National Bureau of Standards were used. Blood pressure phenotypes for this analysis were the mean of the second and third readings for systolic and diastolic BP, that is, systolic and diastolic BP were analyzed as two separate phenotypes. The second and third BP readings were, on average, lower than the first BP reading but similar to each other for both systolic and diastolic BP (Lule, Namara, Akurut, Muhangi, et al., [2019](#mgg3950-bib-0032){ref-type="ref"}).

2.4. Genotyping and quality control {#mgg3950-sec-0010}
-----------------------------------

Earlier in 2013, whole‐genome genotyping of 1,391 EMaBS participants was undertaken. Genotypic data were generated from red cell pellets that had been separated and stored at −80°C until processing. Approximately 2.2 million genetic variants were generated at Wellcome Sanger Institute using the Illumina HumanOmni2.5M‐8 ("octo") Beadchip arrays, version 1.1 (Illumina Inc.). Quality control (using standard pipelines) was performed at the University of Oxford using commands in PLINK (version 1.7; Purcell et al., [2007](#mgg3950-bib-0043){ref-type="ref"}) to remove individuals and variants with high levels of missingness or deviations from expected levels of heterozygosity or Hardy--Weinberg equilibrium (*p* \< 1 × 10^−8^). Untyped genetic variants and the variants identified for replication analysis were imputed in the EMaBS sample using a merged panel (1,000 Genomes Project Consortium et al., [2015](#mgg3950-bib-0003){ref-type="ref"}, African genome variation project \[AGVP\] Gurdasani et al., [2015](#mgg3950-bib-0016){ref-type="ref"} and Uganda 2000 Genomes \[UG2G\]: genomes of Ugandan individuals of diverse ethnicity from rural Uganda) at the Wellcome Centre for Human Genetics. SHAPEIT2 (version 2 790; O\'Connell et al., [2014](#mgg3950-bib-0040){ref-type="ref"}), and IMPUTE2 (version 2.3.2; Marchini, Howie, Myers, McVean, & Donnelly, [2007](#mgg3950-bib-0036){ref-type="ref"}) were used for imputation using settings as recommended for African populations. Only SNPs with an INFO score \>0.3 and a minor allele frequency \>0.01 were taken forward for analysis.

2.5. Association analysis {#mgg3950-sec-0011}
-------------------------

The analysis included EMaBS adolescents with phenotypic and genotypic data. The two outcomes (mean systolic BP and mean diastolic BP) were analyzed separately. GWAS of BP (systolic and diastolic) as quantitative traits was done using mixed linear regression methods (accounting for population substructure) assuming an additive model and controlling for age and body mass index (BMI) as covariates in genome‐wide complex trait analysis (GCTA) version 1.22 (Yang, Lee, Goddard, & Visscher, [2011](#mgg3950-bib-0057){ref-type="ref"}). A *p* \< 5 × 10^−8^ was considered as the threshold to denote genome‐wide significance for SNPs. Results for SNPs with *p* \< 1 × 10^−6^ are reported. Manhattan plots and Quantile--Quantile (Q--Q) plots were constructed to show the distributions of association *p*‐values and the departure of the observed *p*‐values from the null, respectively.

For the replication component of this study, previously published BP GWASs were searched to identify SNPs reported to be associated with systolic or diastolic BP (*p* \< 5 × 10^−8^ in the original GWAS) and these variants were considered for the replication. Replication analysis was conducted using linear regression adjusting for age and BMI in Stata version 14 (College Station, Texas, USA). Variants were tested for association with the phenotype they were associated with in the published GWAS, that is variants associated with systolic BP in a published GWAS were tested for association with systolic BP but not with diastolic BP and vice versa. *P* \< .05 was considered the threshold for statistical significance for the replication study although results were also interpreted in light of a Bonferroni correction allowing for all tests done in the replication analysis.

The base pair position is based on the Genome Reference Consortium Human Build 37, February 2009 (GRCh37/hg19).

3. RESULTS {#mgg3950-sec-0012}
==========

The discovery GWAS analysis used data on 20,074,711 SNPs from 815 adolescents. These adolescents had a mean age of 10.4 years, a mean BMI of 16.0 kg/m^2^, mean systolic BP of 106.0 mmHg, and mean diastolic BP of 65.3 mmHg. Four hundred and seventeen (51%) of the adolescents were male. Detailed characteristics of EMaBS participants included and not included in the analysis are described in Table [S1](#mgg3950-sup-0001){ref-type="supplementary-material"}. Offspring included in the genetic analysis were similar for most characteristics to those not included, except that those included were more likely to have been delivered in Entebbe hospital than elsewhere and to have been exclusively breastfeeding at 6 weeks of age.

The distributions of association *p*‐values (Manhattan plot) for systolic and diastolic BP phenotypes are shown in Figure [1](#mgg3950-fig-0001){ref-type="fig"} and the Q--Q plots in Figure [2](#mgg3950-fig-0002){ref-type="fig"}. The observed P‐values show no departure from the null (Figure [2](#mgg3950-fig-0002){ref-type="fig"}), either for systolic or diastolic BP, with lambda values of 1.006 and 0.995, respectively. The results show adequate control for population substructure in the analysis.

![Manhattan plots for the association of SNPs with (a) systolic blood pressure and (b) diastolic blood pressure adjusting for age and body mass index as fixed covariates](MGG3-7-e00950-g001){#mgg3950-fig-0001}

![Quantile--Quantile (Q--Q) plots for the two phenotypes and the genomic control coefficient (lambda). (a) systolic blood pressure and (b) diastolic blood pressure](MGG3-7-e00950-g002){#mgg3950-fig-0002}

The SNPs most strongly associated with BP are shown in Table [1](#mgg3950-tbl-0001){ref-type="table"}. None of the SNPs reached genome‐wide level of significance (*p* \< 5 × 10^−8^) for association with adolescent systolic or diastolic BP. Borderline significance (5 × 10^−8^ \< *p* \< 1 × 10^−6^) for association with systolic BP was achieved for four index SNPs at four separate loci; there were four SNPs showing borderline significant associations with diastolic BP at four separate loci. There was no overlap between the SNPs most strongly associated with systolic BP and those most strongly associated with diastolic BP. None of these index SNPs have been identified as associated with BP in previously published BP GWAS. The most strongly associated SNP for systolic BP with *p*‐value 6.8 × 10^−7^ was rs181430167, located in the intron region of *KLHL29* on chromosome 2. The lowest *p*‐value (4.0 × 10^−7^) for association with diastolic BP was for rs12991132 located between *ZFP36L2, THADA, LOC1001297261* on chromosome 2.

###### 

Genome‐wide association study results: SNPs associated with blood pressure (systolic or diastolic) at *p* \< 1.0 × 10^−7^

  Chr                        Nearest gene[a](#mgg3950-note-0004){ref-type="fn"}   Position[b](#mgg3950-note-0005){ref-type="fn"}   SNP           Distance to gene (kb)   Type      EA   RA   EAF    β       *SE*   *p*‐value
  -------------------------- ---------------------------------------------------- ------------------------------------------------ ------------- ----------------------- --------- ---- ---- ------ ------- ------ --------------
  Systolic blood pressure                                                                                                                                                                                          
  2                          KLHL29                                               23904233                                         rs181430167   0                       Intron    C    T    0.05   4.62    9.24   6.8 × 10^−7^
  10                         LINC00701                                            2565732                                          rs71502208    500                     Unknown   A    G    0.22   2.51    5.05   9.3 × 10^−7^
  3                          SGOL1/SGOL‐ASI                                       20295100                                         rs139992073   200                     Unknown   C    T    0.14   2.83    5.74   9.7 × 10^−7^
  3                          PLXNA1                                               126737466                                        rs73861745    0                       Intron    A    G    0.26   2.25    4.57   9.9 × 10^−7^
  Diastolic blood pressure                                                                                                                                                                                         
  2                          ZFP36L2/THADA/LOC1001297261                          43291689                                         rs12991132    500                     Unknown   A    G    0.59   −1.87   3.61   4.0 × 10^−7^
  2                          COBLL                                                165534347                                        rs111770209   20                      Unknown   T    C    0.94   −3.82   7.53   4.8 × 10^−7^
  2                          DNAH7                                                196853830                                        rs13403027    0                       Intron    A    G    0.71   −1.91   3.87   9.1 × 10^−7^
  4                          ANK2                                                 114209732                                        rs29356       0                       Intron    T    C    0.69   1.91    3.87   9.6 × 10^−7^

Abbreviations: Chr, chromosomes; EA, effect allele; EAF, effect allele frequency; RA, reference allele; SE, standard error; SNP, single nucleotide polymorphism; β, effect size estimates correspond to mean difference in mmHg per effect allele for systolic or diastolic blood pressure, adjusted for age and body mass index.

Named according to the nearest annotated gene(s).

Given with respect to Build 37 (GRCh37/hg19).

John Wiley & Sons, Ltd

Of the 389 SNPs (Adeyemo et al., [2009](#mgg3950-bib-0002){ref-type="ref"}; Cho et al., [2009](#mgg3950-bib-0005){ref-type="ref"}; Ehret et al., [2016](#mgg3950-bib-0008){ref-type="ref"}; International Consortium for Blood Pressure Genome‐Wide Association Studies et al., [2011](#mgg3950-bib-0009){ref-type="ref"}; Evangelou et al., [2018](#mgg3950-bib-0011){ref-type="ref"}; Fox et al., [2011](#mgg3950-bib-0012){ref-type="ref"}; Franceschini et al., [2013](#mgg3950-bib-0013){ref-type="ref"}; Ganesh et al., [2014](#mgg3950-bib-0014){ref-type="ref"}, [2013](#mgg3950-bib-0015){ref-type="ref"}; Ho et al., [2011](#mgg3950-bib-0018){ref-type="ref"}; Hoffmann et al., [2017](#mgg3950-bib-0019){ref-type="ref"}; Johnson, Newton‐Cheh, et al., [2011](#mgg3950-bib-0021){ref-type="ref"}; Johnson, Gaunt, et al., [2011](#mgg3950-bib-0022){ref-type="ref"}; Kato et al., [2015](#mgg3950-bib-0023){ref-type="ref"}, [2011](#mgg3950-bib-0024){ref-type="ref"}; Kidambi et al., [2012](#mgg3950-bib-0026){ref-type="ref"}; Levy et al., [2009](#mgg3950-bib-0027){ref-type="ref"}; Li et al., [2017](#mgg3950-bib-0028){ref-type="ref"}; Liang et al., [2017](#mgg3950-bib-0029){ref-type="ref"}; Liu et al., [2016](#mgg3950-bib-0030){ref-type="ref"}; Newton‐Cheh, Johnson, et al., [2009](#mgg3950-bib-0037){ref-type="ref"}; Newton‐Cheh, Larson, et al., [2009](#mgg3950-bib-0038){ref-type="ref"}; Parmar et al., [2016](#mgg3950-bib-0041){ref-type="ref"}; Simino et al., [2014](#mgg3950-bib-0046){ref-type="ref"}; Surendran et al., [2016](#mgg3950-bib-0047){ref-type="ref"}; Takeuchi et al., [2010](#mgg3950-bib-0048){ref-type="ref"}; Tragante et al., [2014](#mgg3950-bib-0050){ref-type="ref"}; Wain et al., [2017](#mgg3950-bib-0051){ref-type="ref"}, [2011](#mgg3950-bib-0052){ref-type="ref"}; Warren et al., [2017](#mgg3950-bib-0053){ref-type="ref"}) identified for replication, 330 (85%) SNPs were included in the replication analysis. Fifty‐nine SNPs that were either rare (\<0.01) or poorly imputed (INFO score \<0.3) in the EMaBS sample were not included in the replication analysis. Thirty SNPs of the 330 SNPs included in the replication had been previously associated with BP in populations of African origins. Forty SNPs had been previously associated with both systolic and diastolic BP and were tested for association with both. Tables [2](#mgg3950-tbl-0002){ref-type="table"} and [3](#mgg3950-tbl-0003){ref-type="table"} show results from the replication analysis. Briefly, 33 SNPs (17 for systolic, 15 for diastolic and one for both systolic and diastolic BP) were associated with BP in this population, with the same effect direction as the discovery population for 14 of the SNPs (five for systolic BP and eight for diastolic BP and one for both systolic and diastolic BP).

###### 

Loci associated with systolic blood pressure identified from previous GWAS and results of replication in Entebbe Mother and Baby Study (EMaBS) sample

  Chr      SNP               Position[a](#mgg3950-note-0008){ref-type="fn"}   Nearest gene               Population    EA/RA     Discovery sample   EMaBS sample                                                                                                           
  -------- ----------------- ------------------------------------------------ -------------------------- ------------- --------- ------------------ -------------- ---------- ------------------- ---------- -------------------------------------------------- ---------- ------------------
  1        rs839755          43856410                                         SZT2                       E             A/C       0.62               −0.27          0.03       5.4 × 10^‒18^       0.81       0.29                                               0.70       6.8 × 10^‒1^
  **1**    **rs4926499**     **249155909**                                    **AL672294.1**             **E**         **C/G**   **0.82**           **0.30**       **0.04**   **1.3 × 10^‒11^**   **0.98**   **−5.12**                                          **2.00**   **1.1 × 10^‒2^**
  1        rs1043069         180859368                                        XPR1                       E             T/G       0.62               0.23           0.03       5.2 × 10^‒14^       0.63       0.02                                               0.62       9.7 × 10^‒1^
  1        rs4651224         184585182                                        C1orf21                    E             T/C       0.45               0.20           0.03       9.0 × 10^‒11^       0.94       0.75                                               1.24       5.5 × 10^‒1^
  1        rs2807337         22577371                                         WNT4                       E             T/C       0.37               0.19           0.03       2.8 × 10^‒9^        0.43       −0.70                                              0.58       2.3 × 10^‒1^
  **1**    **rs7514579**     **94051350**                                     **BCAR3**                  **E**         **A/C**   **0.77**           **0.22**       **0.03**   **5.5 × 10^‒10^**   **0.50**   **1.25** [c](#mgg3950-note-0010){ref-type="fn"}    **0.67**   **4.0 × 10^‒2^**
  1        rs17396055        94730954                                         ARHGAP29                   E             A/G       0.33               −0.17          0.03       4.0 × 10^‒8^        0.08       0.80                                               1.02       4.3 × 10^‒1^
  1        rs12042924        197297417                                        CRB1                       E             T/C       0.53               −0.18          0.03       2.6 × 10^‒9^        0.86       −1.29                                              0.86       1.3 × 10^‒1^
  1        rs7555285         209970355                                        IRF6                       E             C/G       0.80               0.23           0.04       1.1 × 10^‒9^        0.83       −0.52                                              0.77       5.0 × 10^‒1^
  1        rs33996239        203109801                                        ADORA1                     E             T/C       0.06               −0.37          0.07       3.4 × 10^‒8^        0.09       −0.13                                              1.08       9.0 × 10^‒1^
  1        rs2932538         113216543                                        MOV10                      E             G/A       0.75               0.39           ---        1.2 × 10^‒9^        0.85       0.15                                               0.80       8.6 × 10^‒1^
  1        rs7515635         42408070                                         HIVEP3                     E             T/C       0.47               0.31           0.04       4.8 × 10^‒12^       0.68       0.08                                               0.65       9.0 × 10^‒1^
  1        rs17367504        11862778                                         MTHFR‐NPPB                 E             G/A       0.14               −0.85          0.11       2.0 × 10^‒13^       0.09       0.66                                               1.10       5.5 × 10^‒1^
  1        rs2493292         3328659                                          PRDM16                     E/AA          T/C       0.15               0.37           0.07       1.4 × 10^‒8^        0.17       −0.36                                              0.82       6.6 × 10^‒1^
  1        rs880315          10796866                                         CASZ1                      AS            C/T       0.34               1.08           0.03       2.2 × 10^‒8^        0.11       −0.91                                              0.96       3.5 × 10^‒1^
  1        rs3820068         15798197                                         CELA2A                     E             A/G       0.81               0.43           0.06       1.1 × 10^‒8^        0.63       0.81                                               0.63       2.0 × 10^‒1^
  1        rs10922502        89360158                                         GTF2B                      E             A/G       0.62               −0.38          0.05       2.2 × 10^‒15^       0.67       −0.32                                              0.64       6.1 × 10^‒1^
  **2**    **rs2972146**     **227100698**                                    **2q36.3**                 **E**         **T/G**   **0.65**           **0.17**       ---        **8.4 × 10^‒9^**    **0.86**   **−0.19**                                          **0.86**   **4.0 × 10^‒2^**
  2        rs1446468         164963486                                        FIGN‐GRB14                 E             T/C       0.53               −0.50          0.07       1.8 × 10^‒12^       0.95       0.46                                               1.34       7.3 × 10^‒1^
  2        rs16849225        164906820                                        FIGN‐GRB14                 AS            C/T       0.61               0.75           0.11       3.5 × 10^‒11^       0.89       −1.04                                              0.93       2.7 × 10^‒1^
  2        rs7562            28635740                                         FOSL2                      E             T/C       0.52               0.26           0.05       1.9 × 10^‒8^        0.26       0.20                                               0.67       7.6 × 10^‒1^
  2        rs13420463        37517566                                         PRKD3                      E             A/G       0.77               0.36           0.05       7.0 × 10^‒11^       0.45       0.03                                               0.63       9.6 × 10^‒1^
  2        rs55780018        208526140                                        METTL21A‐AC079767.3        E             T/C       0.54               −0.39          0.05       5.9 × 10^‒16^       0.75       0.59                                               0.74       4.2 × 10^‒1^
  **2**    **rs1275988**     **26914364**                                     **KCNK3**                  **E**         **T/C**   **0.23**           **−0.60**      **0.09**   **2.6 × 10^‒10^**   **0.14**   **2.01**                                           **0.85**   **1.8 × 10^‒2^**
  **2**    **rs6712094**     **165043460**                                    **FIGN‐GRB14**             **E**         **A/G**   **0.70**           **0.60**       **0.10**   **9.9 × 10^‒9^**    **0.89**   **−3.72**                                          **1.01**   **2.6 × 10^‒4^**
  2        rs1344653         19730845                                         OSR1                       E/AS          A/G       0.54               −0.27          0.04       7.8 × 10^‒12^       0.67       0.07                                               0.66       9.1 × 10^‒1^
  2        rs2300481         66782467                                         MEIS1                      E             T/C       0.39               0.20           0.03       1.6 × 10^‒10^       0.37       0.73                                               0.61       2.3 × 10^‒1^
  2        rs35590893        43716933                                         HADA                       E             A/G       0.27               −0.24          0.03       1.7 × 10^‒12^       0.13       0.52                                               0.86       5.5 × 10^‒1^
  2        rs67720684        18975439                                         NT5C1B                     E             A/C       0.24               0.19           0.04       3.8 × 10^‒8^        0.36       −0.41                                              0.60       5.0 × 10^‒1^
  2        rs28377357        112769721                                        MERTK                      E             A/G       0.29               −0.21          0.03       9.6 × 10^‒11^       0.31       0.87                                               0.64       1.8 × 10^‒1^
  2        rs72816333        60096560                                         RP11−444A22.1              E             A/T       0.83               0.23           0.04       5.5 × 10^‒9^        0.96       −0.15                                              1.48       9.2 × 10^‒1^
  2        rs28558491        187816321                                        ZSWIM2                     E             T/C       0.74               −0.21          0.03       7.5 × 10^‒10^       0.29       0.55                                               0.67       4.1 × 10^‒1^
  2        rs6723509         122000745                                        TFCP2L1                    E             T/C       0.86               0.25           0.04       7.6 × 10^‒9^        0.91       0.78                                               1.00       4.4 × 10^‒1^
  2        rs1044822         230629138                                        TRIP12                     E             T/C       0.15               −0.25          0.04       5.2 × 10^‒9^        0.09       −0.41                                              1.07       7.0 × 10^‒1^
  2        rs12694277        213188795                                        ERBB4                      E             T/C       0.30               −0.20          0.03       1.8 × 10^‒9^        0.62       −0.05                                              0.61       9.4 × 10^‒1^
  2        rs6739913         185033065                                        ZNF804A                    E             A/G       0.28               0.18           0.03       6.5 × 10^‒8^        0.21       0.21                                               0.71       7.6 × 10^‒1^
  **2**    **rs2920899**     **55279681**                                     **RTN4**                   **E**         **T/G**   **0.79**           **0.20**       **0.04**   **9.5 × 10^‒8^**    **0.86**   **1.58** [c](#mgg3950-note-0010){ref-type="fn"}    **0.78**   **4.0 × 10^‒2^**
  3        rs9810888         53635595                                         CACNA1D                    AS            G/T       0.39               0.53           0.10       5.5 × 10^‒8^        0.60       −1.15                                              0.60       5.4 × 10^‒2^
  3        rs11128722        14958126                                         FGD5                       E             A/G       0.56               −0.31          0.05       3.6 × 10^‒11^       0.32       0.39                                               0.10       5.2 × 10^‒1^
  3        rs9859176         134000025                                        RYK                        E             T/C       0.40               0.32           0.05       1.3 × 10^‒11^       0.17       0.57                                               0.77       4.6 × 10^‒1^
  3        rs419076          169100886                                        MECOM                      E             T/C       0.47               0.41           ---        1.8 × 10^‒13^       0.57       −0.60                                              0.61       3.2 × 10^‒1^
  3        rs347591          11290122                                         HRH1                       E/AS/AA       G/T       0.35               −0.53          0.11       1.5 × 10^‒8^        0.57       −0.41                                              0.60       4.9 × 10^‒1^
  3        rs13082711        27537909                                         SL4A7                      E             T/C       0.78               −0.24          ---        3.8 × 10^‒9^        0.95       −0.33                                              1.41       8.1 × 10^‒1^
  3        rs319690          47927484                                         MAP4                       E             T/C       0.50               0.42           0.07       4.7 × 10^‒8^        0.44       0.72                                               0.62       2.5 × 10^‒1^
  3        rs12638085        30405936                                         TGFBR2                     E             A/T       0.35               0.22           0.03       5.6 × 10^‒12^       0.12       −1.31                                              0.92       1.6 × 10^‒1^
  3        rs6788984         41107173                                         CTNNB1                     E             A/G       0.86               0.30           0.04       3.8 × 10^‒12^       0.71       −0.05                                              0.66       9.4 × 10^‒1^
  **3**    **rs9875380**     **132780356**                                    **TMEM108**                **E**         **T/C**   **0.46**           **−0.18**      **0.03**   **6.5 × 10^‒9^**    **0.26**   **−1.55** [c](#mgg3950-note-0010){ref-type="fn"}   **0.68**   **2.3 × 10^‒2^**
  3        rs863930          135949737                                        PCCB                       E             A/C       0.54               0.19           0.03       5.1 × 10^‒10^       0.63       −0.77                                              0.62       2.2 × 10^‒1^
  3        rs78151625        158316726                                        MLF1                       E             T/C       0.83               −0.25          0.04       1.6 × 10^‒9^        −0.82      3.49                                               3.49       8.1 × 10^‒1^
  3        rs6774721         49381898                                         ARIH2                      E             C/T       0.88               0.28           0.05       6.4 × 10^‒9^        0.83       −0.94                                              0.85       3.7 × 10^‒1^
  3        rs9857362         74710462                                         CNTN3                      E             A/C       0.53               0.17           0.03       1.6 × 10^‒8^        0.83       0.65                                               0.77       3.9 × 10^‒1^
  4        rs1458038         81164723                                         FGF5                       E             T/C       0.29               0.71           ---        1.5 × 10^‒23^       0.04       1.28                                               1.53       4.1 × 10^‒1^
  4        rs2291435         38387395                                         TBC1D1‐FLJ13197            E/AA          T/C       0.52               −0.34          0.04       1.9 × 10^‒14^       0.30       −0.54                                              0.64       4.0 × 10^‒1^
  4        rs13112725        106911742                                        NPNT                       E             C/G       0.76               0.44           0.06       1.5 × 10^‒14^       0.61       −0.62                                              0.60       3.0 × 10^‒1^
  4        rs231708          2694773                                          FAM193A                    E             C/G       0.69               −0.12          0.03       4.7 × 10^‒18^       0.24       1.14                                               0.68       9.6 × 10^‒2^
  4        rs7439567         138464842                                        P11−714L20.1               E             T/C       0.42               0.25           0.03       2.3 × 10^‒16^       0.81       −0.58                                              0.76       4.4 × 10^‒1^
  4        rs2610990         18008232                                         LCORL                      E             A/G       0.26               −0.29          0.03       2.8 × 10^‒17^       0.19       −1.19                                              0.77       1.2 × 10^‒1^
  **4**    **rs17035181**    **157678511**                                    **PDGFC**                  **E**         **T/G**   **0.85**           **0.31**       **0.04**   **7.6 × 10^‒13^**   **0.75**   **−1.47**                                          **0.71**   **3.8 × 10^‒2^**
  4        rs1347345         95938386                                         MPR1B                      E             A/G       0.62               −0.18          0.03       6.9 × 10^‒9^        0.87       0.23                                               0.88       8.0 × 10^‒1^
  4        rs12511987        46595623                                         GABRA2                     E             T/G       0.82               −0.23          0.04       5.4 × 10^‒9^        0.94       −0.53                                              1.45       7.2 × 10^‒1^
  4        rs2014912         86715670                                         ARHGAP24                   E/AS          T/C       0.16               0.62           0.08       5.4 × 10^‒17^       0.16       1.16                                               0.82       1.6 × 10^‒1^
  5        rs13359291        122476457                                        PRDM6                      E/AS          A/G       0.31               0.53           0.07       8.9 × 10^‒16^       0.16       0.66                                               0.77       3.9 × 10^‒1^
  5        rs1173771         32815028                                         NPR3‐C5orf23               E             G/A       0.60               0.50           ---        1.8 × 10^‒16^       0.82       1.09                                               0.82       1.9 × 10^‒1^
  5        rs11953630        157845402                                        EBF1                       E             T/C       0.37               −0.41          ---        3.0 × 10^‒11^       0.13       −0.34                                              0.88       7.0 × 10^‒1^
  5        rs10077885        114390121                                        TRIM36                     E             A/C       0.50               −0.28          0.04       1.6 × 10^‒10^       0.65       0.20                                               0.63       7.5 × 10^‒1^
  5        rs6595838         127868199                                        FBN2                       E             A/G       0.30               0.34           0.05       7.6 × 10^‒12^       0.63       0.62                                               0.59       2.9 × 10^‒1^
  5        rs1173766         32804528                                         NPR3                       AS            C/T       0.60               0.63           0.11       1.9 × 10^‒8^        0.66       1.13                                               0.64       7.8 × 10^‒1^
  5        rs10069690        1279790                                          TERT                       E             T/C       0.26               0.31           0.04       4.8 × 10^‒17^       0.66       −0.54                                              0.65       4.0 × 10^‒1^
  5        rs709668          96174186                                         CTD−2260A17.2              E             A/G       0.20               −0.29          0.04       6.0 × 10^‒15^       0.40       −0.43                                              0.59       4.7 × 10^‒1^
  5        rs246973          68007803                                         SLC30A5                    E             T/C       0.29               0.25           0.03       1.5 × 10^‒13^       0.40       2.51                                               1.53       1.0 × 10^‒1^
  5        rs702395          140086677                                        ZMAT2                      E             T/C       0.44               0.23           0.03       3.5 × 10^‒14^       0.29       −0.15                                              0.65       8.2 × 10^‒1^
  5        rs13179413        55868097                                         AC022431.2                 E             T/C       0.28               0.22           0.03       1.1 × 10^‒10^       0.21       −0.23                                              0.72       7.5 × 10^‒1^
  **5**    **rs62373688**    **127352807**                                    **CTC−228N24.3**           **E**         **A/T**   **0.13**           **0.27**       **0.04**   **1.5 × 10^‒9^**    **0.24**   **1.40** [c](#mgg3950-note-0010){ref-type="fn"}    **0.70**   **4.6 × 10^‒2^**
  5        rs74774746        33411769                                         TARS                       E             C/G       0.26               −0.19          0.04       5.6 × 10^‒8^        0.14       1.49                                               0.88       9.2 × 10^‒2^
  5        rs1008058         122435627                                        PRDM6                      E             A/G       0.14               0.55           ---        3.0 × 10^‒10^       0.13       0.31                                               0.89       7.3 × 10^‒1^
  6        rs79030490        134087689                                        TARID‐TCF21                AA            A/C       0.09               −1.83          0.31       3.0 × 10^‒9^        0.11       0.99                                               1.19       4.0 × 10^‒1^
  6        rs76987554        134080855                                        TARID‐TCF21                AA            C/T       0.91               1.85           0.31       2.2 × 10^‒9^        0.90       −0.88                                              1.20       4.6 × 10^‒1^
  6        rs1799945         26091179                                         HFE                        E             G/C       0.14               0.63           ---        7.7 × 10^‒12^       0.02       −1.84                                              2.17       4.0 × 10^‒1^
  **6**    **rs805303**      **31616366**                                     **BAT2‐BAT5**              **E**         **G/A**   **0.61**           **0.38**       ---        **1.5 × 10^‒11^**   **0.40**   **1.66** [c](#mgg3950-note-0010){ref-type="fn"}    **0.61**   **7.0 × 10^‒3^**
  6        rs6911827         22130601                                         CASC15                     E             T/C       0.45               0.30           0.05       2.0 × 10^‒10^       0.82       0.81                                               0.81       3.2 × 10^‒1^
  6        rs2270860         43270151                                         SLC22A7                    E/AA          T/C       0.37               0.32           0.05       2.9 × 10^‒11^       0.78       −1.20                                              0.71       9.1 × 10^‒2^
  **6**    **rs1563788**     **43308363**                                     **TTBK1‐SLC22A7‐ZNF318**   **E/AS**      **T/C**   **0.31**           **0.51**       **0.06**   **2.2 × 10^‒16^**   **0.78**   **−1.46**                                          **0.71**   **4.0 × 10^‒2^**
  6        rs13209747        127115454                                        RSPO3                      E/AA/AS       T/C       0.19               0.85           0.21       2.6 × 10^‒10^       0.07       −0.13                                              1.09       9.1 × 10^‒1^
  6        rs17080102        151004770                                        PLEKHG1                    E/AA/AS       C/G       0.10               −1.02          0.25       4.8 × 10^‒8^        0.15       −0.61                                              0.81       4.5 × 10^‒1^
  6        rs9368222         20686996                                         CDKAL1                     E             A/C       0.27               0.23           0.03       1.8 × 10^‒11^       0.17       −0.07                                              0.81       9.3 × 10^‒1^
  6        rs10782230        126228512                                        NCOA7                      E             A/G       0.48               0.21           0.03       2.9 × 10^‒12^       0.41       0.71                                               0.62       2.6 × 10^‒1^
  6        rs2745599         1613686                                          FOXC1                      E             A/G       0.55               0.22           0.03       9.8 × 10^‒12^       0.10       −1.48                                              0.95       1.2 × 10^‒1^
  6        rs9885632         131311909                                        EPB41L2                    E             T/C       0.73               0.24           0.03       4.3 × 10^‒12^       0.94       0.64                                               1.39       6.4 × 10^‒1^
  6        rs7763294         140383733                                        CITED2                     E             T/G       0.32               −0.20          0.03       6.4 × 10^‒10^       0.10       0.32                                               0.97       7.4 × 10^‒1^
  7        rs2969070         2512545                                          CHST12‐LFNG                E             A/G       0.63               −0.30          0.05       1.4 × 10^‒10^       0.97       −0.01                                              1.80       1.0 × 10^‒0^
  7        rs11556924        129663496                                        ZC3HC1                     E             T/C       0.38               −0.28          0.05       7.6 × 10^‒9^        0.01       −0.24                                              1.58       8.8 × 10^‒1^
  7        rs13238550        131059056                                        MKLN1                      E             A/G       0.40               0.33           0.05       1.9 × 10^‒12^       0.09       −0.14                                              1.14       9.0 × 10^‒1^
  7        rs1011018         139463264                                        HIPK2                      E             A/G       0.20               −0.33          0.06       1.5 × 10^‒8^        0.61       −0.17                                              0.59       7.8 × 10^‒1^
  7        rs4728142         128573967                                        7q32.1                     E             A/G       0.43               −0.24          ‐          3.5 × 10^‒8^        0.23       −0.27                                              0.69       7.0 × 10^‒1^
  7        rs17477177        106411858                                        PIK3CG                     E             T/C       0.72               −0.55          0.08       5.7 × 10^‒11^       0.94       −0.86                                              1.15       4.5 × 10^‒1^
  7        rs17428471        27337867                                         EVX1‐HOXA                  E/AA/AS       T/G       0.14               1.20           0.24       2.1 × 10^‒12^       0.13       1.39                                               0.90       1.3 × 10^‒1^
  7        rs11563582        27351650                                         EVX1‐HOXA                  AA            A/G       0.13               1.61           0.28       7.1 × 10^‒9^        0.17       0.56                                               0.81       4.9 × 10^‒1^
  7        rs848445          77572461                                         PHTF2                      E             T/C       0.23               −0.20          0.03       2.3 × 10^‒9^        0.08       −0.09                                              1.03       9.3 × 10^‒1^
  7        rs6963105         75097488                                         POM121C                    E             A/G       0.43               −0.19          0.03       3.8 × 10^‒9^        0.06       0.17                                               1.15       8.8 × 10^‒1^
  7        rs10274928        28142088                                         JAZF1                      E             A/G       0.49               0.16           0.03       8.2 × 10^‒8^        0.66       −0.05                                              0.63       9.3 × 10^‒1^
  7        rs11771693        150050111                                        RARRES2                    E             A/G       0.67               0.18           0.03       1.9 × 10^‒8^        0.52       −0.25                                              0.62       6.8 × 10^‒1^
  8        rs4841569         11452177                                         BLK‐GATA4                  E/AS          G/A       0.51               0.47           0.02       5.6 × 10^‒10^       0.91       0.33                                               1.13       7.7 × 10^‒1^
  8        rs2898290         11433909                                         BLK‐GATA4                  E             T/C       0.53               0.53           0.80       3.2 × 10^‒8^        0.61       −0.71                                              0.60       2.3 × 10^‒1^
  **8**    **rs1986971**     **10268736**                                     **MSRA**                   **E**         **A/G**   **0.70**           **0.26**       **0.03**   **1.6 × 10^‒14^**   **0.80**   **1.45** [c](#mgg3950-note-0010){ref-type="fn"}    **0.73**   **4.8 × 10^‒2^**
  8        rs1906672         38130025                                         WHSC1L1                    E             A/G       0.23               0.30           0.04       1.2 × 10^‒16^       0.16       0.08                                               0.82       9.2 × 10^‒1^
  8        rs72688070        81393697                                         Y_RNA                      E             T/C       0.17               −0.27          0.04       2.8 × 10^‒11^       0.44       −0.62                                              0.60       3.0 × 10^‒1^
  **8**    **rs62491354**    **9730663**                                      **TNKS**                   **E**         **A/G**   **0.13**           **0.31**       **0.04**   **3.3 × 10^‒12^**   **0.13**   **−2.38**                                          **0.80**   **3.0 × 10^‒3^**
  8        rs4129585         143312933                                        TSNARE1                    E             A/C       0.44               0.19           0.03       1.0 × 10^‒9^        0.06       −1.10                                              1.18       3.5 × 10^‒1^
  8        rs6557876         25900675                                         EBF2                       E             C/T       0.25               −0.37          0.05       2.8 × 10^‒14^       0.50       −0.20                                              0.60       7.4 × 10^‒1^
  8        rs894344          135612745                                        ZFAT                       E             A/G       0.60               −0.26          0.05       3.2 × 10^‒8^        0.65       −0.17                                              0.64       8.0 × 10^‒1^
  9        rs10760117        123586737                                        PSMD5                      E             T/G       0.42               0.28           0.05       6.1 × 10^‒10^       0.78       −1.39                                              0.72       5.3 × 10^‒2^
  9        rs1332813         9350706                                          PTPRD                      E             T/C       0.35               0.22           0.03       2.3 × 10^‒12^       0.36       0.02                                               0.62       9.7 × 10^‒1^
  **9**    **rs7045409**     **95201540**                                     **CENPP**                  **E**         **A/T**   **0.37**           **−0.19**      **0.03**   **2.6 × 10^‒9^**    **0.90**   **2.16**                                           **0.94**   **2.2 × 10^‒2^**
  9        rs1891730         130309028                                        FAM129B                    E             T/C       0.62               −0.18          0.03       7.7 × 10^‒9^        0.39       −1.13                                              0.61       6.2 × 10^‒2^
  9        rs28558845        4334791                                          GLIS3                      E             C/G       0.16               −0.26          0.04       1.2 × 10^‒9^        0.24       0.29                                               0.72       6.9 × 10^‒1^
  10       rs1133400         134459388                                        INPP5A                     E             A/G       0.79               −0.30          0.04       2.5 × 10^‒15^       0.86       0.11                                               0.88       9.0 × 10^‒1^
  10       rs11191548        104846178                                        CYP17A1‐NT5C2              E             T/C       0.91               1.16           0.12       7.0 × 10^‒24^       0.98       −0.41                                              1.62       8.0 × 10^‒1^
  **10**   **rs112184198**   **102604514**                                    **PAX2**                   **E**         **A/G**   **0.10**           **−0.66**      **0.08**   **3.6 × 10^‒18^**   **0.06**   **3.67**                                           **1.37**   **8.0 × 10^‒3^**
  10       rs1813353         18707448                                         CACNB2                     E             T/C       0.68               0.57           ---        2.6 × 10^‒12^       0.84       −0.74                                              0.84       3.8 × 10^‒1^
  10       rs932764          95895940                                         PLCE1                      E             G/A       0.44               0.48           ---        7.1 × 10^‒16^       0.15       0.59                                               0.85       4.9 × 10^‒1^
  10       rs1801253         115805056                                        ADRB1                      E             G/C       0.27               −0.57          0.09       4.7 × 10^‒10^       0.34       0.21                                               0.64       7.5 × 10^‒1^
  10       rs4387287         105677897                                        OBFC1                      E/AS          A/C       0.16               0.36           ---        9.1 × 10^‒10^       0.73       −0.00                                              0.67       1.0 × 10^‒0^
  10       rs4590817         63467553                                         C10orf107                  E             G/C       0.84               0.65           ---        4.0 × 10^‒12^       0.84       −0.55                                              0.78       4.8 × 10^‒1^
  10       rs7912283         133773019                                        PPP2R2D                    E             A/G       0.35               0.21           0.03       6.4 × 10^‒11^       0.89       −0.31                                              0.89       7.3 × 10^‒1^
  10       rs12572586        74751579                                         PLA2G12B                   E             T/C       0.94               −0.39          0.06       1.2 × 10^‒9^        0.95       1.91                                               1.41       1.8 × 10^‒1^
  10       rs11197813        118523933                                        HSPA12A                    E             A/G       0.70               −0.18          0.03       3.5 × 10^‒8^        0.82       0.97                                               0.74       1.9 × 10^‒1^
  10       rs4373814         18419972                                         CACNB2                     E             G/C       0.55               −0.37                     4.8 × 10^‒11^       0.39       −0.82                                              0.60       1.7 × 10^‒1^
  11       rs7103648         47461783                                         RAPSN‐PSMC3‐SLC39A13       E             A/G       0.61               −0.33          0.05       4.4 × 10^‒13^       0.85       0.97                                               0.85       2.6 × 10^‒1^
  11       rs751984          61278246                                         LRRC10B                    E             T/C       0.88               0.41           0.07       3.8 × 10^‒9^        0.79       0.04                                               0.72       9.5 × 10^‒1^
  11       rs661348          1905292                                          LSP1‐TNNT3                 E             T/C       0.57               −0.65          0.11       7.0 × 10^‒10^       0.86       0.89                                               0.98       3.3 × 10^‒1^
  11       rs7129220         10350538                                         ADM                        E             G/A       0.89               −0.62          ---        3.0 × 10^‒12^       0.92       −1.02                                              1.16       3.8 × 10^‒1^
  11       rs633185          100593538                                        FLJ32810‐TMEM133           E             G/C       0.28               −0.57          ---        1.2 × 10^‒17^       0.23       −0.92                                              0.71       2.0 × 10^‒1^
  11       rs4757391         16302939                                         SOX6                       E/AS/AA       T/C       0.21               0.56           0.12       5.7 × 10^‒10^       0.74       0.19                                               0.65       7.7 × 10^‒1^
  11       rs11229457        58207203                                         OR5B12                     E/AS          T/C       0.24               −0.31          ---        2.7 × 10^‒8^        0.29       −0.36                                              0.62       5.6 × 10^‒1^
  11       rs381815          16902268                                         PLEKHA7                    E             T/C       0.26               0.57           ---        5.3 × 10^‒11^       0.26       −0.27                                              0.71       5.6 × 10^‒1^
  11       rs3741378         65408937                                         RELA                       E             T/C       0.14               −0.55          ---        3.4 × 10^‒10^       0.76       −1.04                                              0.69       1.3 × 10^‒1^
  11       rs4385883         51539339                                         TRIM48                     E             T/A       0.29               −0.25          0.04       1.4 × 10^‒12^       0.53       −0.10                                              0.60       8.6 × 10^‒1^
  11       rs11041530        7701503                                          CYB5R2                     AA            C/G       0.11               −1.35          0.25       4.0 × 10^‒8^        0.17       0.49                                               0.82       5.5 × 10^‒1^
  11       rs1401454         16250183                                         SOX6                       AA            T/C       0.46               0.55           0.16       5.6 × 10^‒8^        0.46       −0.60                                              0.59       3.1 × 10^‒1^
  11       rs7941684         5532222                                          UBQLN3                     AA            T/G       0.80               −1.23          0.22       2.4 × 10^‒8^        0.82       −0.69                                              0.80       3.8 × 10^‒1^
  11       rs11031051        30355707                                         ARL14EP                    E             A/C       0.69               −0.22          0.03       7.7 × 10^‒12^       0.58       0.26                                               0.61       6.7 × 10^‒1^
  **11**   **rs67976715**    **68023742**                                     **C11orf24**               **E**         **C/G**   **0.23**           **0.21**       **0.04**   **6.8 × 10^‒9^**    **0.07**   **−2.44**                                          **1.23**   **4.8 × 10^‒2^**
  11       rs10743086        8774923                                          ST5                        E             A/G       0.21               −0.21          0.04       3.6 × 10^‒8^        0.33       0.96                                               0.61       1.2 × 10^‒1^
  12       rs11067763        116198341                                        MED13L                     AS            A/G       0.62               0.81           0.10       5.7 × 10^‒16^       0.78       0.42                                               0.68       5.4 × 10^‒1^
  12       rs10858966        90567026                                         ATP2B1                     E             C/G       0.29               0.26           0.03       9.2 × 10^‒15^       0.02       0.86                                               2.17       6.9 × 10^‒1^
  12       rs2024385         12888438                                         APOLD1                     E             A/T       0.42               −0.26          0.03       5.9 × 10^‒18^       0.46       −0.57                                              0.59       3.4 × 10^‒1^
  12       rs11571376        1059556                                          RAD52                      E             C/G       0.70               −0.18          0.03       5.7 × 10^‒8^        0.73       −0.49                                              0.71       4.9 × 10^‒1^
  12       rs6487543         26438189                                         SSPN                       E             A/G       0.77               0.30           0.05       6.3 × 10^‒10^       0.08       −0.41                                              1.05       7.0 × 10^‒1^
  **12**   **rs2681492**     **90013089**                                     **ATP2B1**                 **E/AS/AA**   **G/A**   **0.17**           **−0.97**      **0.16**   **5.8 × 10^‒8^**    **0.15**   **1.84**                                           **0.79**   **2.1 × 10^‒2^**
  12       rs10850411        115387796                                        TBX5‐TBX3                  E             T/C       0.70               0.35           ---        5.4 × 10^‒8^        0.61       −0.45                                              0.60       4.5 × 10^‒1^
  **12**   **rs17249754**    **90060586**                                     **ATP2B1**                 **E**         **G/A**   **0.84**           **0.93**       ---        **1.8 × 10^‒18^**   **0.85**   **−1.58**                                          **0.80**   **4.8 × 10^‒2^**
  12       rs10437954        58003922                                         ARHGEF25                   E             A/G       0.90               −0.41          0.05       1.6 × 10^‒14^       0.67       0.61                                               0.66       3.5 × 10^‒1^
  12       rs5742643         102837863                                        IGF1                       E             A/G       0.25               −0.22          0.03       2.0 × 10^‒10^       0.26       −0.67                                              0.69       3.3 × 10^‒1^
  12       rs7963801         79685226                                         SYT1                       E             T/C       0.41               −0.24          0.03       2.8 × 10^‒14^       0.01       3.33                                               2.54       1.9 × 10^‒1^
  12       rs7976167         24210599                                         SOX5                       E             T/C       0.69               0.18           0.03       3.8 × 10^‒8^        0.84       1.61                                               0.82       5.1 × 10^‒2^
  13       rs9532243         32191408                                         RXFP2                      E             A/C       0.48               0.22           0.03       8.2 × 10^‒14^       0.55       −0.33                                              0.59       5.8 × 10^‒1^
  13       rs606950          22298923                                         FGF9                       E             A/G       0.62               0.27           0.03       3.2 × 10^‒18^       0.47       0.88                                               0.60       1.4 × 10^‒1^
  13       rs78474310        73826901                                         KLF5                       E             A/G       0.96               −0.47          0.07       1.5 × 10^‒10^       0.99       −0.72                                              3.38       8.3 × 10^‒1^
  13       rs9526707         51489186                                         RNASEH2B                   E             A/G       0.32               −0.20          0.03       2.7 × 10^‒10^       0.12       −1.59                                              0.91       8.0 × 10^‒2^
  13       rs9549328         113636156                                        MCF2L                      E             T/C       0.23               0.32           0.06       1.5 × 10^‒8^        0.15       0.59                                               0.89       5.1 × 10^‒1^
  14       rs8014182         103859962                                        MARK3                      E             T/C       0.14               −0.33          0.04       5.2 × 10^‒14^       0.02       0.19                                               1.93       9.2 × 10^‒1^
  14       rs11159091        75074316                                         LTBP2                      E             A/G       0.46               0.20           0.03       6.7 × 10^‒11^       0.01       2.00                                               2.77       4.7 × 10^‒1^
  14       rs11623535        72462381                                         RGS6                       E             A/G       0.74               0.21           0.03       1.0 × 10^‒9^        0.57       0.71                                               0.60       2.4 × 10^‒1^
  14       rs17115145        30122409                                         PRKD1                      E             T/C       0.40               0.18           0.03       7.4 × 10^‒9^        0.57       −0.33                                              0.58       5.7 × 10^‒1^
  14       rs9888615         53377540                                         FERMT2                     E             T/C       0.29               −0.32          0.05       3.5 × 10^‒10^       0.62       0.38                                               0.63       5.4 × 10^‒1^
  14       rs8016306         63928546                                         PPP2R5E                    E             A/G       0.80               0.34           0.06       3.7 × 10^‒9^        0.15       −0.10                                              0.84       9.1 × 10^‒1^
  15       rs1563894         68635775                                         TGA11                      E             A/G       0.19               −0.09          ---        2.9 × 10^‒8^        0.69       0.17                                               0.63       7.8 × 10^‒1^
  15       rs2521501         91437388                                         FURIN‐FES                  E             T/A       0.31               0.65           ---        5.2 × 10^‒9^        0.21       −0.39                                              0.76       6.1 × 10^‒1^
  15       rs1378942         75077367                                         CYP1A1‐ULK3                E             C/A       0.35               0.61           ---        5.7 × 10^‒23^       0.97       −0.03                                              1.70       9.9 × 10^‒1^
  15       rs35199222        81013037                                         ABHD17C                    E             A/G       0.45               0.32           0.05       5.2 × 10^‒12^       0.07       0.39                                               1.18       7.5 × 10^‒1^
  15       rs11632436        86295286                                         RP11−158M2.4               E             C/G       0.50               0.22           0.03       2.0 × 10^‒13^       0.21       −0.31                                              0.73       6.7 × 10^‒1^
  15       rs3743157         85680532                                         PDE8A                      E             A/C       0.17               0.29           0.04       4.2 × 10^‒13^       0.71       0.10                                               0.66       8.8 × 10^‒1^
  15       rs4965529         100145224                                        MEF2A                      E             T/G       0.17               −0.26          0.04       5.4 × 10^‒11^       0.31       −0.16                                              0.64       8.0 × 10^‒1^
  16       rs11639856        24788645                                         TNRC6A                     E/AA          A/T       0.19               −0.34          0.06       1.3 × 10^‒8^        0.19       0.90                                               0.78       2.5 × 10^‒1^
  16       rs11643209        75331044                                         CFDP1                      E             T/G       0.42               −0.34          0.05       1.8 × 10^‒12^       0.74       0.08                                               0.70       9.1 × 10^‒1^
  16       rs7187540         85318302                                         LINC00311                  E             A/C       0.34               −0.20          0.03       1.0 × 10^‒8^        0.15       0.01                                               0.89       9.9 × 10^‒1^
  17       rs4925159         18185510                                         TOP3A                      E             A/G       0.43               0.22           0.03       9.7 × 10^‒13^       0.73       0.29                                               0.63       6.5 × 10^‒1^
  17       rs34430710        56876627                                         PPM1E                      E             A/T       0.68               −0.21          0.03       5.0 × 10^‒11^       0.89       0.95                                               0.89       2.9 × 10^‒1^
  17       rs1036902         58950791                                         BCAS3                      E             T/C       0.84               −0.25          0.04       1.7 × 10^‒9^        0.19       −0.14                                              0.73       8.5 × 10^‒1^
  17       rs1551355         30032420                                         RP11−805L22.1              E             T/C       0.23               0.21           0.04       3.9 × 10^‒9^        0.03       −0.05                                              1.94       9.8 × 10^‒1^
  17       rs12940887        47402807                                         ZNF652                     E             T/C       0.38               0.36           ---        1.8 × 10^‒10^       0.07       −0.48                                              1.43       7.4 × 10^‒1^
  17       rs57927100        75317300                                         SEPT9                      E             C/G       0.26               −0.31          0.05       4.0 × 10^‒14^       0.78       −0.60                                              0.70       3.9 × 10^‒1^
  17       rs2467099         73949045                                         ACOX1                      E             T/C       0.22               −0.30          0.06       3.3 × 10^‒8^        0.12       −0.82                                              0.95       3.9 × 10^‒1^
  17       rs12941318        1333598                                          CRK                        E             T/C       0.49               −0.27          0.05       2.5 × 10^‒8^        0.75       0.67                                               0.66       3.1 × 10^‒1^
  17       rs12946454        43208121                                         PLCD3                      E             T/A       0.28               0.50           0.17       1.0 × 10^‒8^        0.06       −0.06                                              1.20       9.6 × 10^‒1^
  17       rs7406910         46688256                                         HOXB7                      E/AS          T/C       0.12               −0.46          ---        3.8 × 10^‒8^        0.26       0.38                                               0.65       5.6 × 10^‒1^
  17       rs112280096       79367409                                         RP11−1055B8.6              E             A/C       0.36               −0.20          0.04       1.3 × 10^‒9^        0.06       0.68                                               1.45       6.4 × 10^‒1^
  18       rs12958173        42141977                                         SETBP1                     E             A/C       0.31               0.36           0.05       1.4 × 10^‒13^       0.32       0.72                                               0.63       2.6 × 10^‒1^
  18       rs12454712        60845884                                         BCL2                       E             T/C       0.62               0.19           0.03       5.8 × 10^‒9^        0.76       0.86                                               0.70       2.2 × 10^‒1^
  18       rs10048404        54578482                                         WDR7                       E             T/C       0.37               −0.26          0.03       1.9 × 10^‒16^       0.05       −1.12                                              1.33       4.9 × 10^‒1^
  18       rs11876341        48799991                                         MEX3C                      E             A/G       0.69               −0.21          0.03       1.8 × 10^‒10^       0.94       2.01                                               1.48       1.8 × 10^‒1^
  19       rs4247374         7252756                                          INSR                       E             T/C       0.14               −0.59          0.08       1.2 × 10^‒18^       0.02       −0.93                                              2.23       6.7 × 10^‒1^
  20       rs1327235         10969030                                         JAG1                       E             G/A       0.46               0.34           ---        1.9 × 10^‒8^        0.59       −0.03                                              0.59       9.6 × 10^‒1^
  20       rs6015450         57751117                                         GNAS‐EDN3                  E             G/A       0.12               0.90           ---        3.9 × 10^‒23^       0.18       0.51                                               0.74       5.0 × 10^‒1^
  21       rs12627651        44760603                                         CRYAA‐SIK1                 E             A/G       0.29               0.39           0.05       2.6 × 10^‒14^       0.07       1.70                                               1.28       5.9 × 10^‒1^
  22       rs4823006         29451671                                         ZNRF3                      E/AA          G/A       0.42               −0.26          0.05       7.9 × 10^‒9^        0.40       0.86                                               0.58       1.4 × 10^‒1^
  22       rs28578714        50727921                                         PLXNB2                     E             T/C       0.61               0.21           0.03       2.5 × 10^‒10^       0.53       −0.59                                              0.58       3.1 × 10^‒1^

Bold indicate *p* \< 5.0 × 10^−2^ for replication analysis.

Abbreviations: AA, African ancestry; AS, Asian ancestry; Chr, chromosomes; E, European ancestry; EA, effect allele; EAF, effect allele frequency; RA, reference allele; SE, standard error; SNP, single nucleotide polymorphism; β, Effect size estimates correspond to mean difference in mmHg per effect allele for systolic or diastolic blood pressure, adjusted for age and body mass index.

Given with respect to Build 37 (GRCh37/hg19).

Adjusted for age and body mass index.

Indicate same β direction in both the discovery and EMaBS populations.

John Wiley & Sons, Ltd

###### 

Loci associated with diastolic blood pressure identified from previous GWAS and results of replication in Entebbe Mother and Baby Study (EMaBS) sample

  Chr      SNP              Position[a](#mgg3950-note-0013){ref-type="fn"}   Nearest gene           Population    EA/RA     Discovery sample   EMaBS sample                                                                                                           
  -------- ---------------- ------------------------------------------------ ---------------------- ------------- --------- ------------------ -------------- ---------- ------------------- ---------- -------------------------------------------------- ---------- ------------------
  1        rs17367504       11862778                                         MTHFR/NPPB             E             G/A       0.15               −0.55          ---        3.5 × 10^‒19^       0.09       −0.53                                              0.97       5.8 × 10^‒1^
  **1**    **rs2169137**    **204497913**                                    **MDM4**               **E/AS/AA**   **G/C**   **0.27**           **−0.36**      **0.07**   **5.9 × 10^‒8^**    **0.23**   **1.32**                                           **0.61**   **3.1 × 10^‒2^**
  1        rs13306561       11865804                                         MTHFR                  E/AS/AA       G/A       0.15               −0.52          0.09       3.0 × 10^‒19^       0.27       0.04                                               0.58       9.4 × 10^‒1^
  1        rs2932538        113216543                                        MOV10                  E             G/A       0.75               0.24           ---        9.9 × 10^‒10^       0.85       −0.25                                              0.70       3.6 × 10^‒1^
  1        rs4846049        11850365                                         MTHFR‐NPPB             E             T/G       0.33               −0.55          0.10       6.7 × 10^‒8^        0.51       0.72                                               0.50       1.6 × 10^‒1^
  1        rs6686889        25030470                                         chr1mb25               E             T/C       0.25               0.19           0.03       3.6 × 10^‒9^        0.36       −0.28                                              0.53       5.9 × 10^‒1^
  1        s12405515        172357441                                        DNM3                   E             T/G       0.56               −0.17          0.03       1.4 × 10^‒9^        0.20       0.68                                               0.66       3.0 × 10^‒1^
  1        s12408022        217718789                                        GPATCH2                E             T/C       0.26               0.20           0.03       2.4 × 10^‒10^       0.06       −0.43                                              1.14       7.1 × 10^‒1^
  1        rs10916082       227252626                                        CDC42BPA               E             A/G       0.73               −0.18          0.03       8.4 × 10^‒9^        0.52       −0.06                                              0.52       9.1 × 10^‒1^
  1        rs2760061        228191075                                        WNT3A                  E             A/T       0.47               0.23           0.03       2.1 × 10^‒16^       0.62       −0.02                                              0.56       9.7 × 10^‒1^
  1        rs953492         243471192                                        SDCCAG8                E             A/G       0.46               0.22           0.03       7.4 × 10^‒16^       0.68       −0.18                                              0.56       7.5 × 10^‒1^
  1        rs2004776        230848702                                        AGT                    E             T/C       0.23               0.32           0.06       5.0 × 10^‒8^        0.52       −0.45                                              0.52       3.9 × 10^‒1^
  1        rs1565716        29549216                                         MECR                   E             A/G       0.07               0.21           0.03       3.5 × 10^‒10^       0.09       0.66                                               1.02       5.2 × 10^‒1^
  1        rs35981664       218549354                                        TGFB2                  E             A/T       0.69               −0.16          0.02       2.0 × 10^‒17^       0.99       −0.58                                              3.69       8.8 × 10^‒1^
  1        rs12142296       46541679                                         PIK3R3                 E             T/G       0.86               −0.16          0.03       8.9 × 10^‒11^       0.98       1.09                                               1.66       5.1 × 10^‒1^
  1        rs72704264       145713305                                        CD160                  E             C/G       0.21               0.12           0.02       3.6 × 10^‒8^        0.03       0.58                                               1.44       6.9 × 10^‒1^
  2        rs1446468        164963486                                        FIGN‐GRB14             E             T/C       0.53               −0.50          0.07       6.9 × 10^‒9^        0.95       −0.61                                              1.17       6.1 × 10^‒1^
  2        rs16823124       183224127                                        PDE1A                  E             A/G       0.42               0.26           0.04       2.0 × 10^‒10^       0.11       −0.06                                              0.80       9.4 × 10^‒1^
  **2**    **rs55701159**   **25139596**                                     **ADCY3**              **E**         **T/G**   **0.89**           **0.29**       **0.04**   **7.2 × 10^‒11^**   **0.89**   **−1.98**                                          **0.79**   **1.3 × 10^‒2^**
  2        rs4952611        40567743                                         SLC8A1                 E             T/C       0.58               −0.16          0.03       4.0 × 10^‒8^        0.72       −0.08                                              0.59       9.0 × 10^‒1^
  2        rs2579519        96675166                                         GPAT2‐FAHD2CP          E             T/C       0.63               −0.20          0.03       4.8 × 10^‒12^       0.72       0.01                                               0.61       9.9 × 10^‒1^
  2        rs7592578        191439591                                        TMEM194B               E             T/G       0.19               −0.24          0.04       9.5 × 10^‒12^       0.27       −0.81                                              0.61       1.8 × 10^‒1^
  2        rs1063281        218668732                                        TNS1                   E             T/C       0.60               −0.20          0.03       1.3 × 10^‒12^       0.59       0.28                                               0.55       6.1 × 10^‒1^
  2        rs1975487        55809054                                         PNPT1                  E             A/G       0.46               −0.16          0.03       1.8 × 10^‒9^        0.68       0.02                                               0.55       9.7 × 10^‒1^
  2        rs1220128        158499902                                        ACVR1C                 E             C/G       0.85               0.19           0.02       6.2 × 10^‒15^       0.40       0.20                                               0.53       7.1 × 10^‒1^
  2        rs1996992        219651349                                        CYP27A1                E             T/G       0.05               −0.30          004        4.7 × 10^‒14^       0.09       −1.00                                              0.93       2.8 × 10^‒1^
  2        rs13001283       127183454                                        GYPC                   E             A/G       0.16               0.15           0.02       1.9 × 10^‒10^       0.11       0.81                                               0.79       3.1 × 10^‒1^
  2        rs7606205        144146311                                        ARHGAP15               E             A/C       0.70               −0.13          0.02       2.4 × 10^‒11^       0.49       −0.40                                              0.53       4.5 × 10^‒1^
  2        rs34570306       146272860                                        ZEB2                   E             T/C       0.53               −0.12          0.02       1.2 × 10^‒11^       0.07       −0.00                                              1.04       1.0 × 10^‒1^
  2        rs4851462        98357163                                         ZAP70                  E             T/C       0.63               −0.12          0.02       4.0 × 10^‒11^       0.90       −0.46                                              0.91       6.2 × 10^‒1^
  2        rs2707238        38094149                                         LINC00211              E             C/G       0.28               0.10           0.02       6.8 × 10^‒8^        0.28       −0.42                                              0.60       4.8 × 10^‒1^
  3        rs11128722       14958126                                         FGD5                   E             A/G       0.56               −0.17          0.03       5.1 × 10^‒10^       0.32       0.55                                               0.53       3.0 × 10^‒1^
  3        rs918466         64710253                                         ADAMTS9                E             A/G       0.41               −0.18          0.03       1.7 × 10^‒11^       0.90       0.57                                               0.86       5.1 × 10^‒1^
  3        rs36022378       49913705                                         CAMKV‐ACTBP13          E             T/C       0.80               −0.20          0.03       4.7 × 10^‒9^        0.98       −0.37                                              2.44       8.8 × 10^‒1^
  3        rs743757         50476378                                         CACNA2D2               E             C/G       0.14               0.25           0.04       2.4 × 10^‒10^       0.55       −0.60                                              0.54       2.7 × 10^‒1^
  3        s9827472         56726646                                         FAM208A                E             T/C       0.37               −0.18          0.03       4.3 × 10^‒10^       0.48       0.19                                               0.52       7.0 × 10^‒1^
  3        rs2306374        138119952                                        MRAS                   E             T/C       0.84               −0.18          0.03       7.4 × 10^‒9^        0.96       2.03                                               1.37       1.4 × 10^‒1^
  3        rs12374077       185317674                                        SENP2                  E             C/G       0.35               0.16           0.03       9.2 × 10^‒9^        0.47       0.52                                               0.52       3.2 × 10^‒1^
  3        rs143112823      154707967                                        RP11−439C8.2           E             A/G       0.09               −0.40          0.05       1.4 × 10^‒14^       0.09       −0.41                                              0.99       6.8 × 10^‒1^
  3        rs419076         169100886                                        MECOM                  E             T/C       0.47               0.24           ---        2.1 × 10^‒12^       0.57       −0.29                                              0.54       5.8 × 10^‒1^
  3        rs319690         47927484                                         MAP4                   E             T/C       0.50               0.28           0.05       1.8 × 10^‒8^        0.44       0.26                                               0.55       6.3 × 10^‒1^
  3        rs1706003        194299967                                        TMEM44                 E             T/G       0.47               0.12           0.02       5.8 × 10^‒12^       0.01       −3.51                                              2.17       1.1 × 10^‒1^
  3        rs11923667       101268080                                        TRMT10C                E             A/T       0.41               0.12           0.02       3.1 × 10^‒11^       0.27       −1.06                                              0.57       6.5 × 10^‒2^
  3        rs6777317        197070959                                        DLG1                   E             A/G       0.92               0.12           0.02       1.5 × 10^‒10^       0.90       0.76                                               0.92       4.1 × 10^‒1^
  3        rs4634143        23163749                                         UBE2E2                 E             T/C       0.30               0.12           0.02       7.9 × 10^‒10^       0.07       0.10                                               1.06       9.3 × 10^‒1^
  3        rs3774372        41877414                                         ULK4                   E             T/C       0.83               −0.37          ---        9.0 × 10^‒14^       0.77       −0.72                                              0.59       2.2 × 10^‒1^
  4        rs13139571       156645513                                        GUCY1A3‐GUCY1B3        E             C/A       0.76               0.26           ---        2.2 × 10^‒10^       0.86       0.89                                               0.75       2.4 × 10^‒1^
  4        rs6825911        111381638                                        ENPEP                  AS            C/T       0.51               0.39           0.07       9.0 × 10^‒9^        0.61       0.46                                               0.55       4.0 × 10^‒1^
  4        rs2291435        38387395                                         TBC1D1‐FLJ13197        E/AA          T/C       0.52               −0.16          0.03       4.3 × 10^‒9^        0.30       0.07                                               5.58       9.0 × 10^‒1^
  4        rs66887589       120509279                                        PDE5A                  E             T/C       0.52               −0.22          0.03       3.4 × 10^‒15^       0.62       −0.46                                              0.55       4.0 × 10^‒1^
  4        rs1458038        81164723                                         FGF5                   E             T/C       0.29               0.46           ---        8.5 × 10^‒25^       0.04       0.98                                               1.35       4.7 × 10^‒1^
  4        rs223361         103769304                                        UBE2D3                 E             T/C       0.66               0.17           0.02       2.7 × 10^‒20^       0.48       −0.10                                              0.54       8.5 × 10^‒1^
  4        rs28667801       26785356                                         STIM2                  E             A/T       0.59               −0.16          0.02       1.9 × 10^‒19^       0.87       −0.01                                              0.78       9.9 × 10^‒1^
  4        rs55829085       2165493                                          POLN                   E             A/C       0.95               −0.28          0.04       3.0 × 10^‒11^       0.99       2.13                                               2.50       4.0 × 10^‒1^
  **4**    **rs7694000**    **95324968**                                     **PDLIM5**             **E**         **A/T**   **0.54**           **−0.10**      **0.02**   **3.5 × 10^‒8^**    **0.21**   **2.03**                                           **0.63**   **1.3 × 10^‒3^**
  4        rs62312401       116987529                                        NDST4‐TRAM1L1          AA            C/G       0.94               1.13           0.24       3.5 × 10^‒9^        0.04       −2.14                                              1.39       1.3 × 10^‒1^
  5        rs12521868       131784393                                        C5orf56                E             T/G       0.37               −0.19          ---        6.1 × 10^‒11^       0.04       −0.06                                              1.44       9.6 × 10^‒1^
  5        rs1173771        32815028                                         NPR3‐C5orf23           E             G/A       0.60               0.26           ---        9.1 × 10^‒12^       0.82       1.04                                               0.72       1.5 × 10^‒1^
  5        rs11953630       157845402                                        EBF1                   E             T/C       0.37               −0.28          ---        3.8 × 10^‒13^       0.13       1.27                                               0.77       9.9 × 10^‒2^
  5        rs10077885       114390121                                        TRIM36                 E             A/C       0.50               −0.17          0.03       4.0 × 10^‒11^       0.65       −0.40                                              0.55       4.7 × 10^‒1^
  5        rs6891344        123136656                                        CSNK1G3                E             A/G       0.82               0.23           0.03       1.6 × 10^‒11^       0.72       0.45                                               0.56       4.1 × 10^‒1^
  5        rs10078021       75038431                                         POC5                   E             T/G       0.63               −0.16          0.03       1.3 × 10^‒8^        0.15       −0.41                                              0.69       5.5 × 10^‒1^
  5        rs72812846       173377636                                        CPEB4                  E             A/T       0.28               −0.21          0.03       2.2 × 10^‒11^       0.04       −0.18                                              1.43       9.0 × 10^‒1^
  5        rs10062049       61553881                                         KIF2A                  E             T/C       0.14               0.22           0.02       4.5 × 10^‒18^       0.32       0.62                                               0.63       3.2 × 10^‒1^
  **5**    **rs954767**     **3706050**                                      **IRX1**               **E**         **A/C**   **0.74**           **−0.15**      **0.02**   **4.2 × 10^‒14^**   **0.68**   **1.14**                                           **0.54**   **3.6 × 10^‒2^**
  5        rs55747751       132397351                                        HSPA4                  E             A/G       0.08               −0.22          0.03       1.4 × 10^‒11^       0.01       −0.17                                              2.43       9.4 × 10^‒1^
  **5**    **rs4286632**    **66291370**                                     **MAST4**              **E**         **A/G**   **0.73**           **0.12**       **0.02**   **1.9 × 10^‒9^**    **0.84**   **1.50** [c](#mgg3950-note-0015){ref-type="fn"}    **0.74**   **4.3 × 10^‒2^**
  5        rs2188962        131770805                                        C5orf56                E/AA          T/C       0.37               −0.20          0.03       3.0 × 10^‒11^       0.03       1.25                                               1.70       4.6 × 10^‒1^
  5        rs12515541       57095011                                         ACTBL2                 E             T/G       0.61               0.12           0.02       6.2 × 10^‒11^       0.49       0.08                                               0.54       8.9 × 10^‒1^
  6        rs926552         29548089                                         SNORD32B               E/AA          T/C       0.11               −0.26          0.05       7.2 × 10^‒8^        0.21       −0.25                                              0.63       7.0 × 10^‒1^
  6        rs10943605       79655477                                         PHIP                   E/AA          A/G       0.46               0.16           0.03       3.3 × 10^‒9^        0.28       0.10                                               0.57       8.6 × 10^‒1^
  6        rs13205180       51832494                                         PKHD1                  E             T/C       0.49               0.17           0.03       7.0 × 10^‒10^       0.12       0.43                                               0.81       6.0 × 10^‒1^
  6        rs9372498        118572486                                        SLC35F1                E             A/T       0.08               0.33           0.05       1.8 × 10^‒11^       0.10       0.11                                               0.87       9.0 × 10^‒1^
  6        rs147212971      166178451                                        PDE10A                 E             T/C       0.06               −0.36          0.06       1.6 × 10^‒9^        0.17       0.34                                               0.74       6.5 × 10^‒1^
  6        rs1799945        26091179                                         HFE                    E             G/C       0.14               0.46           ---        1.5 × 10^‒15^       0.02       −0.43                                              1.90       8.2 × 10^‒1^
  **6**    **rs805303**     **31616366**                                     **BAT2‐BAT5**          **E**         **G/A**   **0.61**           **0.23**       **---**    **3.0 × 10^‒11^**   **0.40**   **1.75** [c](#mgg3950-note-0015){ref-type="fn"}    **0.54**   **1.0 × 10^‒3^**
  6        rs13209747       127115454                                        RSPO3                  E/AA/AS       T/C       0.19               0.56           0.12       2.4 × 10^‒11^       0.07       −0.50                                              0.96       6.0 × 10^‒1^
  6        rs17080102       151004770                                        PLEKHG1                E/AA/AS       C/G       0.10               −0.74          0.15       1.9 × 10^‒11^       0.15       −1.21                                              0.70       8.8 × 10^‒2^
  6        rs9472135        43809802                                         VEGFA                  E             T/C       0.70               0.15           0.02       4.3 × 10^‒16^       0.77       0.58                                               0.62       3.5 × 10^‒1^
  6        rs668459         139835689                                        CITED2                 E             T/C       0.59               −0.11          0.02       1.0 × 10^‒10^       0.28       0.02                                               0.57       9.7 × 10^‒1^
  6        rs598682         154418759                                        OPRM1                  E             A/G       0.25               −0.11          0.02       7.2 × 10^‒8^        0.03       0.23                                               1.31       8.6 × 10^‒1^
  **7**    **rs17428471**   **27337867**                                     **EVX1‐HOXA**          **E/AA/AS**   **T/G**   **0.14**           **0.61**       **0.14**   **1.6 × 10^‒9^**    **0.13**   **2.01** [c](#mgg3950-note-0015){ref-type="fn"}    **0.79**   **1.1 × 10^‒2^**
  7        rs2969070        2512545                                          CHST12‐LFNG            E             A/G       0.63               −0.18          0.03       2.9 × 10^‒11^       0.97       −0.24                                              1.58       8.8 × 10^‒1^
  **7**    **rs11556924**   **129663496**                                    **ZC3HC1**             **E**         **T/C**   **0.38**           **−0.21**      **0.03**   **8.2 × 10^‒15^**   **0.01**   **6.90**                                           **2.72**   **1.2 × 10^‒2^**
  7        rs6969780        27159136                                         HOXA3                  E/AA          C/G       0.13               0.26           0.05       1.1 × 10^‒8^        0.39       0.68                                               0.54       2.1 × 10^‒1^
  7        rs891511         150704843                                        NOS3                   E/AA          A/G       0.37               −0.26          0.03       2.0 × 10^‒16^       0.59       −0.55                                              0.52       3.0 × 10^‒1^
  7        rs1947228        96461649                                         SHFM1                  E             T/C       0.42               −0.14          0.02       2.6 × 10^‒16^       0.96       1.01                                               1.29       4.4 × 10^‒1^
  7        rs1722886        134215259                                        AKR1B10                E             A/T       0.57               0.12           0.02       3.8 × 10^‒12^       0.29       −0.05                                              0.57       9.3 × 10^‒1^
  7        rs9638084        156311745                                        LINC01006              E             A/G       0.40               0.12           0.02       8.5 × 10^‒11^       0.55       −0.40                                              0.51       4.3 × 10^‒1^
  7        rs11563582       27351650                                         EVX1‐HOXA              AA            A/G       0.13               1.02           0.17       8.4 × 10^‒10^       0.17       0.80                                               0.71       2.6 × 10^‒1^
  8        rs78192203       142375073                                        GPR20                  AA            T/A       0.80               0.77           0.14       1.3 × 10^‒8^        0.79       −0.29                                              0.65       6.5 × 10^‒1^
  8        rs2978098        101676675                                        SNX31                  E             A/C       0.54               0.17           0.03       1.5 × 10^‒9^        0.03       −0.02                                              1.70       9.9 × 10^‒1^
  8        rs62524579       144060955                                        P11‒273G15.2           E             A/G       0.53               −0.18          0.03       3.8 × 10^‒9^        0.37       0.28                                               0.55       6.2 × 10^‒1^
  8        rs10087782       141858620                                        PTK2                   E             T/C       0.45               0.13           0.02       3.0 × 10^‒14^       0.82       0.32                                               0.67       6.3 × 10^‒1^
  8        rs1047030        22428708                                         SORBS3                 E             A/G       0.81               0.13           0.02       5.7 × 10^‒8^        0.96       −0.80                                              1.23       5.2 × 10^‒1^
  9        rs4364717        21801530                                         MTAP                   E             A/G       0.55               −0.18          0.03       1.3 × 10^‒10^       0.24       0.33                                               0.61       5.8 × 10^‒1^
  9        rs76452347       35906471                                         HRCT1                  E/AA          T/C       0.19               −0.23          0.04       6.8 × 10^‒10^       0.09       −0.16                                              0.92       8.6 × 10^‒1^
  9        rs7020564        109670016                                        ZNF462                 E             A/C       0.70               −0.11          0.02       6.7 × 10^‒9^        0.12       −0.54                                              0.82       5.1 × 10^‒1^
  10       rs4746172        75855842                                         VCL                    E             C/T       ---                0.23           0.04       9.1 × 10^‒8^        0.23       −0.49                                              0.66       4.6 × 10^‒1^
  10       rs1801253        115805056                                        ADRB1                  E             G/C       0.27               −0.36          0.06       9.5 × 10^‒10^       0.34       −0.45                                              0.56       4.2 × 10^‒1^
  10       rs10995311       64564934                                         ADO                    E/AA          G/C       0.38               −0.20          0.03       2.1 × 10^‒11^       0.03       1.36                                               1.47       3.6 × 10^‒1^
  10       rs1530440        63524591                                         C10orf107              E             T/C       0.19               −0.39          0.06       1.0 × 10^‒9^        0.03       −0.87                                              1.58       5.8 × 10^‒1^
  10       rs4590817        63467553                                         C10orf107              E             G/C       0.84               0.42           ---        1.3 × 10^‒12^       0.84       −0.81                                              0.68       2.4 × 10^‒1^
  10       rs2782980        115781527                                        ADRB1                  E             T/C       0.20               −0.28          0.05       9.6 × 10^‒8^        0.47       −0.76                                              0.53       1.5 × 10^‒1^
  10       rs1813353        18707448                                         CACNB2                 E             T/C       0.68               0.42           ---        2.3 × 10^‒15^       0.84       0.16                                               0.73       8.3 × 10^‒1^
  10       rs603424         102075479                                        PKD2L1                 E             A/G       0.18               0.18           0.02       1.2 × 10^‒14^       0.75       0.36                                               0.63       5.7 × 10^‒1^
  10       rs10906391       13523937                                         BEND7                  E             T/C       0.32               0.13           0.02       7.6 × 10^‒12^       0.03       −0.27                                              1.65       8.6 × 10^‒1^
  10       rs4373814        18419972                                         CACNB2(5′)             E             G/C       0.55               −0.22          ---        4.4 × 10^‒10^       0.39       −0.35                                              0.53       5.1 × 10^‒1^
  10       rs11191548       104846178                                        CYP17A1/NT5C2          E             T/C       0.91               0.46           ---        9.4 × 10^‒13^       0.98       1.23                                               1.42       3.9 × 10^‒1^
  11       rs4601790        65353906                                         EHBP1L1                E/AS          G/A       0.27               −0.02          0.04       9.9 × 10^‒9^        0.06       −0.32                                              1.05       7.6 × 10^‒1^
  11       rs7103648        47461783                                         RAPSN‐PSMC3‐SLC39A13   E             A/G       0.61               −0.24          0.03       9.0 × 10^‒19^       0.85       0.78                                               0.74       3.0 × 10^‒1^
  **11**   **rs751984**     **61278246**                                     **LRRC10B**            **E**         **T/C**   **0.88**           **0.38**       **0.04**   **4.2 × 10^‒20^**   **0.79**   **1.56** [c](#mgg3950-note-0015){ref-type="fn"}    **0.63**   **1.4 × 10^‒2^**
  11       rs900145         13293905                                         ARNTL                  E/AA          G/A       0.34               −0.20          0.03       1.8 × 10^‒8^        0.52       0.97                                               0.54       7.0 × 10^‒2^
  11       rs11030119       27728102                                         BDNF                   E             A/G       0.31               −0.16          0.03       2.9 × 10^‒8^        0.35       −0.36                                              0.54       5.1 × 10^‒1^
  11       rs67330701       69079707                                         MYEOV                  E             T/C       0.09               −0.37          0.05       2.1 × 10^‒12^       0.01       0.92                                               2.27       6.9 × 10^‒1^
  **11**   **rs633185**     **100593538**                                    **FLJ32810‐TMEM133**   **E**         **G/C**   **0.28**           **−0.33**      ---        **2.0 × 10^‒15^**   **0.23**   **−1.49** [c](#mgg3950-note-0015){ref-type="fn"}   **6.23**   **1.7 × 10^‒2^**
  11       rs381815         16902268                                         PLEKHA7                E             T/C       0.26               0.35           ---        5.3 × 10^‒14^       0.26       0.58                                               0.62       3.4 × 10^‒1^
  11       rs1401454        16250183                                         SOX6                   E/AA/AS       T/C       0.46               0.45           0.10       5.1 × 10^‒10^       0.46       −0.27                                              0.52       6.1 × 10^‒1^
  11       rs360153         9762274                                          SWAP70                 E             T/C       0.42               −0.22          0.02       4.4 × 10^‒36^       0.52       −0.30                                              0.52       5.7 × 10^‒1^
  11       rs11026586       22515533                                         RP11−34N19.1           E             A/G       0.07               0.29           0.03       2.7 × 10^‒17^       0.06       0.43                                               1.21       7.3 × 10^‒1^
  11       rs875106         70005641                                         ANO1                   E             A/G       0.52               −0.13          0.02       1.7 × 10^‒14^       0.71       1.02                                               5.8        7.7 × 10^‒2^
  11       rs4420291        74374950                                         POLD3                  E             A/G       0.51               0.10           0.02       2.2 × 10^‒8^        0.33       0.08                                               0.58       8.9 × 10^‒1^
  **11**   **rs7129220**    **10350538**                                     **ADM**                **E**         **G/A**   **0.89**           **−0.30**      ---        **6.4 × 10^‒8^**    **0.92**   **−0.79** [c](#mgg3950-note-0015){ref-type="fn"}   **1.01**   **4.4 × 10^‒3^**
  12       rs17249754       90060586                                         ATP2B1                 E             G/A       0.84               0.52           ---        1.2 × 10^‒18^       0.85       −1.89                                              0.69       7.0 × 10^‒1^
  12       rs10850411       115387796                                        TBX5/TBX3              E             T/C       0.70               0.25           ---        5.4 × 10^‒10^       0.61       0.32                                               0.53       5.5 × 10^‒1^
  12       rs1060105        123806219                                        SBNO1                  E/AS          T/C       0.21               −0.18          ---        3.1 × 10^‒8^        0.05       −1.08                                              1.22       3.8 × 10^‒1^
  12       rs2384550        115352731                                        TBX5‐TBX3              E             A/G       0.35               −0.35          0.06       3.7 × 10^‒8^        0.35       −0.93                                              0.53       7.9 × 10^‒2^
  12       rs35444          115552437                                        TBX3                   AS            A/G       0.75               0.50           0.05       1.3 × 10^‒10^       0.56       −0.66                                              0.53       2.1 × 10^‒1^
  12       rs7302981        50537815                                         CERS5                  E/AA          A/G       0.34               0.25           0.03       9.4 × 10^‒19^       0.10       0.90                                               0.84       2.8 × 10^‒1^
  12       rs7132012        8832203                                          RP11−20D14.4           E             A/G       0.68               0.15           0.02       3.2 × 10^‒17^       0.57       0.08                                               0.51       8.8 × 10^‒1^
  12       rs1271309        124820705                                        NCOR2                  E             A/G       0.16               −0.20          0.02       1.5 × 10^‒16^       0.08       0.22                                               0.92       8.1 × 10^‒1^
  12       rs7137749        57098040                                         NACA                   E             T/C       0.37               0.14           0.02       7.2 × 10^‒15^       0.52       −0.44                                              0.52       4.1 × 10^‒1^
  12       rs7134060        96717095                                         CDK17                  E             A/G       0.45               −0.11          0.02       1.1 × 10^‒9^        0.26       −0.93                                              0.60       1.2 × 10^‒1^
  12       rs75507123       5417856                                          RP11−1038A11.3         E             T/G       0.13               −0.14          0.03       3.9 × 10^‒8^        0.02       −0.66                                              1.70       7.0 × 10^‒1^
  12       rs1098708        27321112                                         STK38L                 E             A/G       0.28               −0.10          0.02       4.6 × 10^‒8^        0.82       1.08                                               0.67       1.1 × 10^‒1^
  13       rs55684003       97988689                                         MBNL2                  E             A/G       0.70               0.12           0.02       1.0 × 10^‒10^       0.95       −1.83                                              1.14       1.1 × 10^‒1^
  13       rs9563529        58316637                                         PCDH17                 E             T/G       0.21               0.12           0.02       1.4 × 10^‒8^        0.26       0.56                                               0.59       3.4 × 10^‒1^
  14       rs11628933       60700903                                         PPM1A                  E             C/G       0.23               −0.12          0.02       3.1 × 10^‒9^        0.40       −0.41                                              0.54       4.5 × 10^‒1^
  14       rs4424827        35110857                                         SNX6                   E             T/C       0.57               −0.10          0.02       2.1 × 10^‒8^        0.94       −0.38                                              7.20       9.6 × 10^‒1^
  **15**   **rs7178615**    **66869072**                                     **RP11‒321F6.1**       **E**         **A/G**   **0.37**           **−0.18**      **0.03**   **2.6 × 10^‒10^**   **0.19**   **1.42**                                           **0.69**   **4.1 × 10^‒2^**
  15       rs62012628       79070000                                         ADAMTS7                E             T/C       0.29               −0.24          0.03       5.1 × 10^‒12^       0.31       −0.03                                              0.58       9.6 × 10^‒1^
  15       rs12906962       95312071                                         chr15mb95              E             T/C       0.68               −0.22          0.03       5.6 × 10^‒14^       0.21       −0.73                                              0.64       2.5 × 10^‒1^
  **15**   **rs1378942**    **75077367**                                     **CYP1A1‐ULK3**        **E**         **C/A**   **0.36**           **0.48**       **0.09**   **6.0 × 10^‒8^**    **0.97**   **2.99** [c](#mgg3950-note-0015){ref-type="fn"}    **1.48**   **4.4 × 10^‒2^**
  15       rs2521501        91437388                                         FURIN‐FES              E             T/A       0.31               0.36           ---        1.9 × 10^‒15^       0.21       −1.11                                              0.66       9.5 × 10^‒2^
  15       rs873122         92702020                                         SLCO3A1                E             C/G       0.72               0.12           0.02       6.5 × 10^‒10^       0.94       2.00                                               1.16       8.5 × 10^‒2^
  15       rs7180952        85162551                                         ZSCAN2                 E             T/C       0.54               −0.10          0.02       9.8 × 10^‒9^        0.75       0.02                                               0.61       9.8 × 10^‒1^
  **15**   **rs62004794**   **68454523**                                     **PIAS1**              **E**         **A/G**   **0.44**           **−0.10**      **0.02**   **3.4 × 10^‒8^**    **0.60**   **−1.16** [c](#mgg3950-note-0015){ref-type="fn"}   **0.55**   **3.6 × 10^‒2^**
  16       rs12921187       4943019                                          PPL                    E             T/G       0.43               −0.17          0.03       2.5 × 10^‒10^       0.96       −2.36                                              1.23       5.5 × 10^‒2^
  16       rs72799341       30936743                                         FBXL19                 E             A/G       0.24               0.19           0.03       5.8 × 10^‒9^        0.09       0.03                                               0.90       9.8 × 10^‒1^
  16       rs8059962        81574197                                         CMIP                   E             T/C       0.42               −0.17          0.03       1.3 × 10^‒9^        0.61       0.37                                               0.52       4.8 × 10^‒1^
  16       rs1126464        89704365                                         DPEPI                  E/AA          C/G       0.22               0.24           0.03       2.4 × 10^‒13^       0.06       −0.90                                              1.10       4.2 × 10^‒1^
  16       rs45474499       66914492                                         PDP2                   E             T/C       0.05               0.36           0.04       8.5 × 10^‒18^       0.07       0.85                                               1.09       4.3 × 10^‒1^
  16       rs7185555        69131281                                         HAS3                   E             C/G       0.15               −0.15          0.02       2.3 × 10^‒10^       0.31       0.42                                               0.56       4.6 × 10^‒1^
  **16**   **rs9932866**    **706067**                                       **WDR90**              **E**         **A/G**   **0.37**           **0.12**       **0.02**   **2.9 × 10^‒10^**   **0.90**   **−1.61**                                          **0.80**   **4.5 × 10^‒2^**
  17       rs4308           61559625                                         ACE                    E             A/G       0.37               0.21           0.03       6.8 × 10^‒14^       0.03       −1.29                                              1.73       4.5 × 10^‒1^
  17       rs12940887       47402807                                         ZNF652                 E             T/C       0.38               0.27           ---        2.3 × 10^‒14^       0.07       0.41                                               1.25       7.4 × 10^‒1^
  18       rs12958173       42141977                                         SETBP1                 E             A/C       0.31               0.18           0.03       5.8 × 10^‒10^       0.31       0.68                                               0.56       2.2 × 10^‒1^
  18       rs745821         48142854                                         MAPK4                  E             T/G       0.76               0.19           0.03       1.4 × 10^‒9^        0.70       0.21                                               0.58       7.1 × 10^‒1^
  18       rs34163044       51851616                                         STARD6                 E             A/C       0.42               0.15           0.02       9.6 × 10^‒17^       0.31       −0.13                                              0.59       8.3 × 10^‒1^
  18       rs11665020       10879503                                         PIEZO2                 E             C/G       0.32               −0.14          0.02       2.8 × 10^‒14^       0.14       −0.18                                              0.72       8.1 × 10^‒1^
  18       rs4800420        20158965                                         CTAGE1                 E             A/G       0.29               0.12           0.02       5.2 × 10^‒10^       0.17       −0.63                                              0.70       3.7 × 10^‒1^
  19       rs167479         11526765                                         RGL3                   E/AA          T/G       0.45               −0.30          0.03       4.2 × 10^‒28^       0.17       −0.23                                              0.71       7.4 × 10^‒1^
  19       rs62104477       30294991                                         CCNE1                  E             T/G       0.33               0.18           0.03       1.2 × 10^‒9^        0.25       0.47                                               0.61       4.4 × 10^‒1^
  19       rs4247374        7252756                                          INSR                   E             T/C       0.14               −0.39          0.03       2.1 × 10^‒22^       0.02       −1.85                                              1.96       3.5 × 10^‒1^
  19       rs2304130        19789528                                         ZNF101                 E/AS          A/G       0.91               −0.29          ---        2.0 × 10^‒8^        0.74       −0.63                                              0.59       2.9 × 10^‒1^
  19       rs9710247        40760449                                         AKT2                   E             A/G       0.45               0.16           0.03       1.6 × 10^‒9^        0.90       −1.29                                              0.92       1.6 × 10^‒1^
  19       rs1821295        32590773                                         AC011518.1             E             T/C       0.70               −0.14          0.02       3.1 × 10^‒13^       0.92       −0.06                                              1.14       9.6 × 10^−1^
  20       rs6095241        47308798                                         PREX1                  E/AS          A/G       0.45               −0.17          ---        4.8 × 10^−9^        0.60       −0.42                                              0.53       4.4 × 10^−1^
  20       rs6108168        8626271                                          PLCB1                  E             A/C       0.25               −0.21          0.03       1.1 × 10^−11^       0.62       −0.08                                              0.53       8.8 × 10^−1^
  20       rs1327235        10969030                                         JAG1                   E             G/A       0.46               0.30           ---        1.4 × 10^−15^       0.59       −0.09                                              0.52       8.6 × 10^−1^
  20       rs6015450        57751117                                         GNAS‐EDN3              E             G/A       0.12               0.56           ---        5.6 × 10^−23^       0.18       0.74                                               0.65       2.6 × 10^−1^
  20       rs1232482        11886643                                         BTBD3                  E             T/C       0.40               −0.12          0.02       6.1 × 10^−12^       0.18       −1.26                                              0.70       7.3 × 10^−2^
  **21**   **rs12627651**   **44760603**                                     **CRYAA‐SIK1**         **E**         **A/G**   **0.29**           **0.20**       **0.03**   **1.4 × 10^−11^**   **0.07**   **2.55** [c](#mgg3950-note-0015){ref-type="fn"}    **1.12**   **2.3 × 10^−2^**

Bold indicate *p* \< 5.0 × 10^−2^ for replication analysis.

Abbreviations: AA, African ancestry; AS, Asian ancestry; Chr, chromosomes; E, European ancestry; EA, effect allele; EAF, effect allele frequency; RA, reference allele; SE, standard error;SNP, single nucleotide polymorphism; β, Effect size estimates correspond to mean difference in mmHg per effect allele for systolic or diastolic blood pressure, adjusted for age and body mass index.

Given with respect to Build 37 (GRCh37/hg19).

Adjusted for age and body mass index.

Indicate same β direction in both the discovery and EMaBS populations.

John Wiley & Sons, Ltd

Of the 30 SNPs previously known to be associated with BP specifically in individuals of African origin, three (*ATP2B* rs2681492, *MDM4* rs2169137 and *EVX1*/*HOXA* rs17428471) were associated with BP in the present study. Only the *EVX1*/*HOXA* rs17428471 had the same effect direction as in the discovery population. The *BAT2*/*BAT5* rs805303 variant was associated with systolic BP and diastolic BP of the 40 SNPs tested for association with both traits. The G allele of the *BAT2*/*BAT5* rs805303 variant was associated with higher systolic and higher diastolic BP among adolescents in this study: the same effect direction observed in the discovery population for both traits.

There were 370 independent tests (197 for systolic BP, 173 for diastolic BP) conducted, thus approximately 19 SNPs (370 × 0.05 = 18.5) would be expected to be associated with BP at *p* \< .05 by chance alone. None of the replicated SNPs met a Bonferroni corrected significance threshold (0.05/370 = 1.35 × 10^−4^), although one (rs6712094 intergenic between *FIGN* and *GRB14*) was very close (*p* = 2.6 × 10^−4^) for association with systolic BP. The most strongly associated SNPs for association with diastolic BP were rs805303 between *BAT2* and *BAT5* (*p* = 1.0 × 10^−3^) and *PDLIM5* rs7694000 (*p* = 1.3 × 10^−3^).

4. DISCUSSION {#mgg3950-sec-0013}
=============

To our knowledge, this is the first genetic analysis examining variants associated with BP among African adolescents. We hypothesized that common genetic variants (unique or not unique to populations in Africa) were associated with systolic and, or diastolic BP in Ugandan adolescents and that these associations may overlap with associated variants identified in previous studies of Africans. The GWAS revealed no novel or previously identified variant associated with systolic or diastolic BP in our study population. Thirty‐three SNPs were associated with BP in the replication analysis, with the direction of effect consistent with the discovery population for 14 SNPs. There were no SNPs reaching a Bonferroni‐adjusted significance level. None of the replicated SNPs were located in genes with monogenic effect on hypertension (Ehret & Caulfield, [2013](#mgg3950-bib-0007){ref-type="ref"}).

The SNPs most strongly associated with either systolic or diastolic BP were of borderline significance and none have been reported as associated with BP in previous BP GWASs. The most strongly associated SNPs were mostly common variants with modest effect sizes and might uniquely influence BP in African population. It is important for larger genetic studies of African population to investigate the role of these SNPs in BP regulation among Africans. These top SNPs are potential candidates for replication analysis in African populations.

The failure to identify variants strongly associated with BP presumably occurred because the study was underpowered to detect effects of rare variants or small effects of common variants. Blood pressure is most likely a polygenic trait influenced by the simultaneous presence of several gene variants each with a small effect size and contributing in an additive manner to BP expression. Thus, the large effect sizes that this study had good power to detect, may not be realistic. For example, the present study had 80% power to detect a 3.2 mmHg change in mean systolic BP for a minor allele frequency of 20% at genome‐wide significance level, *p* \< 5 × 10^−8^. Many of the variants reliably associated with BP in adults have an effect size of 0.5 mmHg or less (Evangelou et al., [2018](#mgg3950-bib-0011){ref-type="ref"}). In addition to the limitation caused by the relatively small sample size, imputation did not allow inference for rare variants not included in the imputation SNP panel.

Few GWAS "top SNPs" from non‐African populations have been replicated in populations of African ancestry (Adeyemo et al., [2009](#mgg3950-bib-0002){ref-type="ref"}; Franceschini et al., [2013](#mgg3950-bib-0013){ref-type="ref"}; Kayima et al., [2017](#mgg3950-bib-0025){ref-type="ref"}). Variants associated with BP in populations of African origin might be different from variants that influence BP in Caucasian populations or not in LD with the BP causing variants. Our replication study was limited to variants associated with BP from previous GWAS of BP in other populations. Thirty‐three SNPs identified from previous BP GWAS were replicated, most of these were previously identified in populations of non‐African origins. Of the identified loci, *PAX2* is essential in the development of the renal epithelium (Dressler & Woolf, [1999](#mgg3950-bib-0006){ref-type="ref"}) and plays a critical role in kidney development (Hou, Chen, & Wang, [2011](#mgg3950-bib-0020){ref-type="ref"}). The kidneys are critical in BP regulation. Two of the replicated SNPs are located on *ATP2B1*. *ATP2B1* is involved in calcium homeostasis (Hirawa, Fujiwara, & Umemura, [2013](#mgg3950-bib-0017){ref-type="ref"}). The *ATP2B1* rs2681492, *MDM4* rs2169137, *EVX1*/*HOXA* rs17428471 SNPs previously associated with BP in transethnic populations (African, Caucasian and Asian) were associated with adolescent BP in the present study. These genes most likely influence BP across different ethnic groups.

Replication studies in diverse populations have returned mixed results. This current study conducted 370 tests using 330 SNPs, of which 33 SNPs (one SNP for both traits) were associated with BP. Failure to replicate most variants associated with BP in other populations could be due to differences in minor allele frequencies across populations or differences in LD patterns combined with a poor understanding of the causative variants or due to spurious initial findings. Blood pressure is likely to be influenced by the simultaneous presence of several genetic variants, each conferring a small change in BP.

Although none of the variants reached Bonferroni level of significance more associated variants were identified than expected under the null suggesting that some of these variants found to be associated could be worthy of further follow‐up. Fourteen variants more than those expected by chance (19 variants) under the null hypothesis were associated with BP in this study.

Of the 40 SNPs tested for association with both traits, only *BAT2*/*BAT5* rs805303 was associated with both traits in the adolescents, suggesting that not many genetic loci have influence on both systolic and diastolic BP. Similar to an earlier replication study among adult Ugandans (Kayima et al., [2017](#mgg3950-bib-0025){ref-type="ref"}), the *ATP2B1* rs2681492 was associated with BP in these Ugandan adolescents, but with an opposite effect direction to the discovery population (Hoffmann et al., [2017](#mgg3950-bib-0019){ref-type="ref"}) and Ugandan adults (Kayima et al., [2017](#mgg3950-bib-0025){ref-type="ref"}). The G allele of the *ATP2B1* rs2681492 was associated with lower systolic BP in Ugandans adults (Kayima et al., [2017](#mgg3950-bib-0025){ref-type="ref"}) but with higher systolic BP in the present study.

Some loci may have varying roles in BP regulation across different populations. A European study investigated SNPs associated with BP at different age epochs (using independent samples for each age group): prepuberty (age 4--7 years), pubertal (8--12 years), and postpubertal (13--20 years). The A allele of *TGA11* rs1563894 was associated with lower systolic BP in prepuberty while the T allele of *SMARCA2*/*VLDLR* rs872256 was associated with higher systolic BP during puberty (Parmar et al., [2016](#mgg3950-bib-0041){ref-type="ref"}). No SNP was associated with BP in the postpubertal period, and no SNP was consistently associated with BP across all three age groups. The *TGA11* rs1563894 and *SMARCA2*/*VLDLR* rs872256 were not replicated in this present study.

The present study has several strengths. This is the first BP GWAS of an African population and the first candidate gene analysis among adolescents residing in Africa. Participants in this study were similar to nonparticipants with respect to most baseline characterizes. Rigorous quality control procedures were used during the measurement of the various variables including BP and genotyping. Data from this study can contribute to future BP GWAS meta‐analyses. Key limitations of this study were that it was underpowered to detect effects of rare variants and to enable testing for effect modification by sex and other environmental variables, and the lack of a replication sample from a similar setting with which to confirm our GWAS findings.

Future work should take advantage of various African cohorts to form consortia that can enable the conduct of GWAS meta‐analysis well powered to identify rare and low‐frequency variants that may be associated with BP in African populations. Future candidate gene analysis using a sample from a different geographical region or ethnic background should investigate for interactions between variants, this might help our understanding of the etiology of BP. It is possible that multiple interacting variants (rare and common) are influencing BP levels in this population. Although we did not formally allow for multiple testing in the replication analysis, the current study had 33 associated SNPs 14 more than expected by chance. Polygenic scores analysis of variants associated with BP among African populations may explain the missing BP heritability.

In summary, we conducted the first genetic study of BP phenotypes among Ugandan adolescents. Although this study did not identify novel BP variants, replication of some previously identified variants suggests that some genetic variants may universally influence BP susceptibility. Large scale studies in African populations are required to identify novel and evaluate previously reported loci.
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